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Abstract
Photoplethysmograph sensors use a light-based technology to sense the rate of blood
flow as controlled by the heart’s pumping action. This allows for a graphical display of a
patient’s pulse wave form and the description of its key features. A person’s pulse wave
has been proposed as a tool in a wide variety of applications. For example, it could be
used to diagnose the cause of coldness felt in the extremities or to measure stress levels
while performing certain tasks. It could also be applied to quantify the risk of heart disease
in the general population. In the present work, we explore its use for identity authentication.
First, we visualize the pulse waves from individual patients using functional boxplots
which assess the overall behavior and identify unusual observations. Functional boxplots
are also shown to be helpful in preprocessing the data by shifting individual pulse waves
to a proper starting point. We then employ functional analysis of variance (FANOVA)
and permutation tests to demonstrate that the identities of a group of subjects could be
differentiated and compared by their pulse wave forms. One of the primary tasks of the
project is to confirm the identity of a person, i.e., we must decide if a given person is whom
they claim to be. We used an equivalence test to determine whether the pulse wave of the
person under verification and the actual person were close enough to be considered equivalent.
A nonparametric bootstrap functional equivalence test was applied to evaluate equivalence
by constructing point-wise confidence intervals for the metric of identity assurance. We also
proposed new testing procedures, including the way of building the equivalence hypothesis
and test statistics, determination of evaluation range and equivalence bands, to authenticate
the identity.
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Chapter 1
Introduction
When we use online or offline services, like register to vote, view our driving records or tax
details, apply for an apprenticeship or manage a student loan, we want to be confident that
someone else cannot sign in pretending to be us, see our sensitive personal records or use our
identity to make fraudulent claims. We want to be confident that our data and services are
secure and that our privacy is protected. Here comes the issue of identity authentication. In
contrast to traditional authentication, which would prompt a user for the same credentials
during every login attempt, continuous biometric identification such as pulse wave, deter-
mines the risk associated with the action the user is about to take, based on context gathered
over time continuously, then combines that with what is known about the user to make dy-
namic decisions on how best to authenticate them. In the present work, we explore the use
of photoplethysmography (PPG) for identity authentication.
In Chapter 1, we define the user authentication and functional data and then introduce
a motivating example of continuous biometric authentication by PPG collected from the
pulse oximeter. We also review the existing continuous authentication techniques in Section
1.6.1. However, there are no studies on the use of PPG signals in continuous authentication
systems or how to standardize the PPG amplitude for comparing one waveform to another.
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To use the pulse waves from PPG for authentication, we need show that the variability
among curves between persons is large enough, relative to the variability among curves within
people. We visualize the pulse waves using functional boxplot in Section 2.1 and employ the
functional analysis of variance (FANOVA) in Section 2.2 and the permutation test in Sec-
tion 2.3 to differentiate the subjects when the pulse waves are generated from different people.
However, the primary goal of identity authentication could not be achieved by either
the FANOVA or the permutation test, or traditional hypothesis testing. We propose a new
testing procedure in Chapter 3 to evaluate equivalence for functional data and name it non-
parametric bootstrap functional equivalence test (NBFET). In Chapter 4, we simulate the
pulse wave-like curves from Brownian motion to determine the appropriate equivalence lim-
its and validate the performance of the proposed testing procedure by computing the power
and the type I error rate for various scenarios. Chapter 5 shows the results from real data
applications and a summary of our contributions in this work.
1.1 User Authentication
User authentication is the process of verifying whether the identity of a user is genuine before
granting him access to resources or services in a secure environment. Traditional authenti-
cation methods are based on the user’s knowledge, such as personal identification number
(PIN) and passwords, or something belonging to someone, such as a smart card or cardkey.
It is a well-established fact that traditional passwords are unsafe and may be forgotten, and
identification cards can be lost or misplaced. One of the solutions proposed to prevent such
occurrences is applying continuous authentication, a new generation of security systems that
require the user to re-authenticate themselves in a repeated manner for continued access to
resources in a secure environment.
There has been an increasing interest in biometric systems in recent years. Biometrics
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technologies are widely used in numerous security applications and are considered among
the most accurate and efficient authentication systems on the market. Compared to the con-
ventional methods, biometrics can provide enhanced security and convenience by the use of
a person’s unique, permanent, and universal features recognized from human characteristics.
There are two main types of biometric identifiers: one is physiological characteristics, i.e.,
the shape or composition of the body, and the other is behavioral characteristics, i.e., the
behavior of an individual. Examples of physiological characteristics for biometric authenti-
cation are eye position tracking, pupil size, skin conductivity, relative blood flow, fingertips,
DNA, face, retina, or ear features. Behavioral characteristics are traits that are learned
from human actions, such as typing rhythm, gesture, pace, and voice. Dynamic signature
verification and keystroke dynamics are two examples of behavioral characteristics. So far,
behavioral biometrics have been less successful compared to physiological ones (Bergadano
et al., 2002) because of their significant variability over time.
While some of the above measures may be defined as strong biometrics, others may pro-
vide weak biometrics information for many people but can be discriminative for others. An
example of such a measure is the relative blood flow. Many people may have similar finger-
tip blood flow wave patterns, while some people may have a unique waveform that can be
used as a strong identifier. In this paper, we will investigate the use of a finger-tip blood
flow waveform as the biometric to perform identity authentication.
1.2 Functional Data
Functional data analysis considers responses and predictors for a subject not as a scalar or
vector-valued random variables but instead as random functions defined at infinitely many
points. A functional variable y(t) denotes a variable associated with t, i.e., a function of t,
where t could be time or some other temporal or spatial variable. It could be multidimen-
sional, although, in most cases, we will limit our discussion to a univariate t. When y(t) is
3
Figure 1.1: The heights of 10 girls taken between 1 and 18 years. Circles indicate the ages
at which measurements were taken. These data were collected as part of the Berkeley Growth
Study (Jones and Bayley, 1941).
continuous, a functional variable is called a curve. More formally, a variable is called a func-
tional variable if it takes values in an infinite dimensional space (Ferraty and Vieu, 2006).
Observations of functional variables are called functional data, such as y(ti), i = 1, 2, · · · , n.
Figure 1.1 shows an example of functional data. It displays the height function measured
between 1 and 18 years for each of 10 girls. We view each curve as a functional observation.
Circles indicate the ages at which measurements were taken. Growth is the most rapid in
the earliest years and slows down after the growth spurt that occurs at ages ranging from
about 9 to 15 years. One girl is tall for all ages, but some girls can be tall during childhood,
but end up as a comparatively small adult.
In many research areas, such as medicine, biology, economics and engineering, the data
generating process is naturally a stochastic function. Moreover, many problems are better
approached if the data are considered as functions. For instance, if each curve is observed
at different points, a multivariate analysis would not be valid, and it is necessary to smooth
the data and treat them as continuous functions defined over a common interval.
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In the field of functional data analysis, there are two viewpoints based on how they con-
ceptualize functional data (Ramsay, 1982). On the one hand, some authors view functional
data as a smoothed version of the multivariate data, and functional data analysis applies
the multivariate data analysis techniques in the language of functional observations. On the
other hand, the statistical application of spline functions, especially in the scope of nonpara-
metric function estimation (Eubank, 1999; Silverman et al., 1985; Wahba, 1990) speeds the
development of functional data analysis. Although there is a difference between these two
thoughts, the fundamental idea is that we view the observation as a whole function defined
on a bounded interval, rather than focusing on the individual values at particular points in
the range.
In our project, pulse waves are an example of functional data where we view each wave-
form, instead of individual values at particular points, as a functional observation. Let yij(t)
be the near-infrared PPG signal from the pulse oximeter for the jth curve of person i at
time point t, where i = 1, 2, · · · , 48, j = 1, 2, · · ·ni, and ni is total number of pulse waves
collected for person i.
Typically, in functional data analysis, the primary goal is to discover something about
the smooth curves that underlie the functional observations and to study the behavior of
the entire set of functional data (consisting of many curves). Therefore, smoothing usually
is applied before analyzing functional data. Ramsay (2006) also mentioned that the first
steps in a functional data analysis are data representation: smoothing and interpolation,
data registration or feature alignment, and data display.
5
Figure 1.2: A finger pulse oximeter. Figure from SOS Technologies.
1.3 A motivating example: Authentication by Photo-
plethysmography
The utilization of photoplethysmographic (PPG) signals for biometric identification repre-
sents a novel approach in the area of secure authentication. The word plethysmograph is
a combination of two Greek words “plethysmos” which means increase and “graph” which
means writing (Shelley, 2007). It is mainly used to determine the blood volume or blood flow
in the body associated with each heartbeat. The introduction of the pulse oximeter (Fig-
ure 1.2) into routine clinical care greatly emphasizes the importance of PPG. Photoelectric
plethysmography, also known as PPG, can estimate the skin blood flow using infrared light.
It uses a probe which contains a light source and detector to detect cardiovascular pulse wave
that propagates through the body. There are two application modes for a pulse oximeter:
transmission and reflective (Figure 1.3), depending on where the detector is placed. In the
transmission mode, the detector is placed on a thin part of the body, usually a fingertip
or earlobe. The light will pass through the body part to the photodetector. The detector
can also be placed next to the light source for reflective plethysmography. Reflective pulse
oximetry does not require a thin part of the body and is thus suitable for a universal ap-
plication such as the forehead, feet, and chest. In outpatient settings, pulse oximeters are
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Figure 1.3: Transmission and reflective type pulse oximeter. Graph from Jian Shao and
Qirui Xu, Pulse Oximeter Based Heart Beats Rate Monitor, EE6350 VLSI Design Lab.
commonly worn on the finger. However, in cases such as shock or hypothermia, blood flow
to the periphery can be reduced, resulting in a PPG without a discernible cardiac pulse. In
this case, a PPG can be obtained from a pulse oximeter on the head, with the most common
sites being the ear, forehead, or nasal septum.
The PPG signal reflects the blood movement in the vessel, which goes from the heart
to the fingertips and toes through the blood vessels in a wave-like motion (Tokutaka et al.,
2009), as the amount of the backscattered light corresponds to the variation of the blood
volume (Alnaeb et al., 2007). Figure 1.4 shows a typical waveform of the PPG and its char-
acteristics features. It is most useful to view the waveform from the pulse oximeter as the
measure for the change in blood volume during a heartbeat cycle. The appearance of PPG
pulse can be divided into two stages: the anacrotic stage is the rising edge of the waveform,
whereas the catacrotic phase is the decreasing edge of the waveform as shown in Figure 1.4.
The mounting part is primarily associated with systole and the falling part with diastole.
A dicrotic notch, shown in Figure 1.4, usually occurs during the decreasing phase of people
with healthy compliant arteries. The systolic amplitude (x in Figure 1.4) is an indicator of
the pulse changes in the blood volume caused by arterial blood flow around the measure-
ment site (Asada et al., 2003; Chua and Heneghan, 2006). An example of four consecutive
waveforms are shown in Figure 1.5. Some features based on the PPG have been described
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Figure 1.4: A typical waveform of the PPG and its characteristics parameters: the am-
plitude of the systolic peaks is x while y is the amplitude of the diastolic peak. Figure from
Elgendi (2012).
in the literature.
1) Systolic Amplitude: As shown in Figure 1.4, the systolic amplitude (x) is an indicator
of the pulsatile changes in blood volume caused by blood flow around where the measure-
ment was taken (Asada et al., 2003; Chua and Heneghan, 2006). Systolic amplitude has been
related to stroke volume (Murray and Foster, 1996), which is the volume of blood pumped
from the left ventricle per beat. It is also has been suggested that systolic amplitude is
potentially a more suitable measure than the pulse arrival time for estimating continuous
blood pressure (Chua et al., 2010).
2) Pulse Area: The pulse area is measured as the total area under the PPG curve. Seitso-
nen et al. (2005) found that the PPG area respond to skin incision to differ between movers
and non-movers.
3) Pulse Interval: The distance between the beginning and the end of the PPG waveform.
Poon et al. (2004) suggested that the ratio of pulse interval to its systolic amplitude could
8
Figure 1.5: Consecutive PPG curves.
provide an understanding of the properties of a person’s cardiovascular system.
Compared to other biometric approaches, the PPG technique has distinct advantages
including low cost, easy to use without any complicated procedure, straightforward but ac-
curate to estimate the skin blood flow, heart rate, and blood oxygen saturation. Moreover,
it does not need direct contact with the skin surface, and it is conveniently accessible to the
various location of the body, such as the finger, earlobe, wrist or forehead.
1.4 Purpose of the Study
Identifying an individual based on a username, password or other means helps companies
ensure that the person is whom he or she claims to be when accessing a system, application
or network. However, in some cases, traditional authentication processes are not enough to
provide strong security throughout a user work session. That’s where continuous authenti-
cation comes in. The pulse wave is an important health metric able to perform continuous
authentication and also identify people at increased risk for development of heart disease,
stroke or some other health issues. The research objective is to differentiate and, more im-
portantly, to identify the subjects using their pulse wave curves from PPG, i.e., identity
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assurance. Identity assurance is a set of mechanisms and strategies allowing an organization
to minimize the risk related to identifying impersonation and misappropriation of authenti-
cation credentials.
1.5 Project and Data Description
Dr. Steve Warren, from the Department of Electrical and Computer Engineering, Kansas
State University, provided the pulse wave data for our project. The pulse oximeter prototypes
were used to acquire PPG records from 48 different subjects that are 20 to 64 years old. The
pulse oximeter was placed on the index finger of each individual, and the adjusted near
infrared AC signal was used for data collection. Experimental results were acquired in an
indoor environment. Some were collected at Kansas State University Open House, and thus
may not be as stable as those gathered in the laboratory. Figure 1.6 illustrate 60 seconds
of representative fingertip data from one subject and six single cycles extracted from the
raw signal after shifting to the same starting point at zero. Many people may have similar
finger-tip blood flow wave patterns, while some people may have quite different waveforms
that can be used as a strong identifier.
1.6 Review of Literature
1.6.1 Biometric Identification
Various biometric measures have been investigated for authentication purposes, including
face complexion (Brunelli and Poggio, 1993; Samal and Iyengar, 1992), iris recognition (Ne-
gin et al., 2000), the electrocardiogram (ECG) (Biel et al., 2001; Odinaka et al., 2012),
electroencephalogram (EEG) (Khalifa et al., 2012), phonocardiogram (PCG) (Beritelli and
Serrano, 2007), and photoplethysmogram (PPG) (Bao et al., 2005; Elgendi, 2012; Gu and
Zhang, 2003; Gu et al., 2003; Spachos et al., 2011; Yao et al., 2007). Monrose and Rubin
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Figure 1.6: PPG curves collected from a real person in the project. The upper graph is the
raw PPG signal within around 60 seconds of time, with the current shown on the vertical
axis. The lower one extracted six single cycles from the raw signal and shifted to the same
starting point at zero.
(2000) proposed keystroke biometric technique for continuous authentication. Their method
is based on a single biometric (unimodal technique), so in the absence of keystroke data,
the system is not able to authenticate the user. Altinok and Turk (2003) proposed con-
tinuous authentication techniques using face, voice, and fingerprint. They claimed that a
continuous biometric authentication system should be able to provide a meaningful esti-
mate of authentication certainty at any given time, even in the absence of any biometric
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data. They presented a new temporal integration technique that satisfied this requirement.
Sim et al. (2007) proposed a continuous authentication technique using face and fingerprint
biometrics. They used a mouse with a built-in fingerprint sensor, which made fingerprint
authentication a passive method for authentication. Derawi et al. (2010) collected data with
a commercially available mobile device containing low-grade embedded accelerometers. The
mobile device was placed at the hip on each volunteer to collect gait data. Preprocessing,
cycle detection and recognition-analysis were applied to the acceleration signal. Sitova´ et al.
(2016) introduced Hand Movement, Orientation, and Grasp (HMOG), a set of behavioral
features to continuously authenticate smartphone users. HMOG features capture subtle
micro-movement and orientation dynamics resulting from how a user grasps, holds, and taps
on the smartphone. Buriro et al. (2016) proposed a mechanism which profiles a user based
on how he holds the phone by taking into account the micro-movements of a phone and the
movements of the user’s finger during writing or signing on the touch screen.
The utilization of PPG signals for biometric identification represents a novel approach
in the area of secure authentication. The studies on biometric recognition methods based
on PPG signals have been performed on small datasets and by using algorithms inspired
by medical analysis techniques. Elgendi (2012) has given a comprehensive analysis of the
morphology of fingertip PPG and explained the reasons for their diversity and variation. For
most researchers, the primary concentration has been on the use of peak locations, relative
amplitudes, derivative-based slopes, and time intervals between the interests points. The
method presented in Gu et al. (2003) computes the templates by using four features: the
peak number, upward slope, downward slope, and time interval. However, this approach
ignores the higher-order derivative information contained in the pulse wave, and therefore,
does not make full use of the waveform to improve the identification accuracy. The study
presented in Yao et al. (2007) uses values of the local maximum, minimum, and inflection
points of PPG pulses to evaluate if samples of genuine and impostor individuals present
sufficient discriminability for being used in biometric recognition systems. Kavsaog˘lu et al.
(2014) have used 40 such features, and they applied a feature ranking algorithm with k-means
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clustering. The method described in Spachos et al. (2011) performs biometric recognition
by applying the linear discriminant analysis (LDA) and using an eigenspace decomposition
of the time-domain signal to obtain a template for identification. These methods work well
for datasets with a small number of curves. When the sample datasets get larger, we should
develop more appropriate approaches and algorithms which permit performance of biomet-
ric recognition in a straightforward and fast manner. To the best of our knowledge, there
are no studies on the use of PPG signals in continuous authentication systems or how to
standardize the PPG amplitude/rhythm for comparing one waveform to another.
1.6.2 Statistical Methods for Functional Data
Pulse waves are an example of functional data: each waveform, instead of the individual val-
ues at particular points, represents a functional observation. Due to its practical advantage,
functional data analysis has received considerable attention in diverse areas of applications:
the comparison of growth curves (Rao, 1958), the analysis of handwriting in Chinese (Ram-
say, 2000), modeling price dynamics in online auctions (Wang et al., 2012), crop lodging
assessment (Ogden et al., 2002), forecasting of climate variations (Besse et al., 2000), data
mining (Hand, 2007), ozone population forecasting (Damon and Guillas, 2002), and many
more. Ramsay and Silverman (2002) give numerous examples considering a continuous func-
tional variable. Often, the continuous functional variable is time, which is the case in our
project, even though functional data may be observed over space, wavelength, temperature
or other continuums.
Research tools that are useful for handling functional data include various smoothing
methods, notably kernel regression, local least squares, and spline smoothing for which
various excellent references exist (De Boor et al., 1978; Eubank, 1999; Wand and Jones,
1994), functional analysis (Conway, 2013; Hsing and Eubank, 2015), and stochastic pro-
cesses (Karlin, 2014). Several software packages are publicly available to analyze functional
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data, including software at the Functional Data Analysis website of James Ramsay (http:
//www.psych.mcgill.ca/misc/fda/), the fda package (Ramsay et al., 2015) on the CRAN
project of R (R Core Team, 2013), the Matlab package PACE on the website of the Statistics
Department of the University of California, Davis (http://www.stat.ucdavis.edu/PACE/),
and the R package refund (Goldsmith et al., 2018) on functional regression.
A considerable effort is being made to adapt some standard statistical methods for func-
tional data. This is the case, for example, of principal component analysis (Boente and
Fraiman, 2000; Dauxois et al., 1982; Locantore et al., 1999; Pezzulli and Silverman, 1993;
Ramsay, 2006; Silverman et al., 1996), discriminant analysis (Ferraty and Vieu, 2003), re-
gression (Cardot et al., 1999; Cuevas et al., 2002; Ferraty and Vieu, 2002), and analysis of
variance (Cuevas et al., 2004; Kaufman et al., 2010). Fan and Lin (1998) proposed a two-
sample test and ANOVA test for the mean functions, with further work by Cuevas et al.
(2004) and Zhang (2013). Other two sample tests have been proposed for distributions of
functional data (Hall and Van Keilegom, 2007) and for covariance functions (Panaretos et al.,
2010).
1.6.3 Equivalence Testing
In our project, we are more interested in showing that the pulse waves being compared be-
long to the person owning the sensor because the mistake of claiming the wrong person is
worse than rejecting the correct person. In other words, our inferential goal is to establish
practical similarity rather than a statistically significant difference. If we want to claim
that two groups of pulse waves are “similar,” it is not enough to do the traditional test of
difference and just “not reject,” since failing to find a difference is not proof of similarity.
As a result, we consider equivalence testing where support for the alternative hypothesis of
similarity is provided by evidence against the null hypothesis of difference.
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There are 3 general approaches for equivalence testing: the confidence interval approach,
developed by Westlake (1981) and presented in this proposal; the nonequivalence null hy-
pothesis approach, developed by Anderson and Hauck (1983), which uses an approximation
to a non-central t-distribution to compute the p-value of the test; and Bayesian methods,
developed by Selwyn et al. (1981) and Selwyn and Hall (1984). The first two methods re-
quire the fewest assumptions (Westlake, 1988), and thus, are more appealing. Comparison
of the two approaches shows that the confidence interval approach is more conservative since
the actual Type I error rate is equal to or less than the stated Type I error rate. For the
nonequivalence null hypothesis approach, the actual Type I error rate could be higher than
the stated Type I error rate (Anderson and Hauck, 1983).
Equivalence testing for scalar data has been well addressed in the literature. See Berger
and Hsu (1996) for a comprehensive overview of commonly used procedures. However, the
same cannot be said for functional data. The resultant complexity from maintaining the
functional structure of the data rather than using scalar transformation to reduce the di-
mensionality renders the existing literature on equivalence testing inadequate for desired
inference. Alberola-Lo´pez and Mart´ın-Ferna´ndez (2003) discuss a frequentist approach for
comparing two functions (time series) through the use of a Fourier basis expansion in the
cosinor model. Behseta and Kass (2005) present two methods of testing the hypothesis
of equality of two functions in a generalized non-parametric regression framework using a
recently developed generalized non-parametric regression method called Bayesian adaptive
regression splines (BARS)(DiMatteo et al., 2001). The first method uses Bayes factors, and
the second method uses a modified Hotelling-T 2 test. They applied both methods to the
analysis of 347 motor cortical neurons. All three approaches test strict equality between the
functions of interest but do not establish practical equivalence.
Fogarty and Small (2014) proposed a framework for equivalence testing for functional
data with both the frequentist and Bayesian paradigms. Their frequentist hypothesis test
extends the Two One-Sided Test (TOST) procedure for equivalence testing to the functional
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regime and uses the nonparametric bootstrap (Efron and Tibshirani, 1994) for assessing
equivalence by constructing point-wise confidence intervals for the metric of equivalence.
Their Bayesian methodology employs a functional analysis of variance model and uses a
flexible class of Gaussian processes for modeling the data and the parameters. However, the
authors do not explain how they choose the equivalence bands used in their paper, which is
the most crucial step in equivalence testing.
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Chapter 2
Exploratory Data Analysis
Exploratory Data Analysis (EDA) is the practice of using visual and quantitative methods to
understand and summarize a dataset, usually to investigate a specific question or to prepare
for more advanced modeling, without making any assumptions about its content. It is a
critical first step in analyzing the data from an experiment. EDA often relies on visualizing
the data to assess patterns and identify data characteristics. It also takes advantage of some
quantitative methods to describe the data.
In this chapter, we first apply the functional boxplots in Section 2.1 to detect the out-
liers and visualize the pulse waveforms. We then implement functional analysis of variance
(FANOVA) in Section 2.2 and permutation test in Section 2.3 to differentiate the individu-
als. Based on these preliminary analyses, we find that the variability among curves between
different people is large enough, relative to the variability among curves within a person, to
use these curves for authentication. However, the main objective of identity authentication
cannot be achieved by either the FANOVA or the permutation test, we propose more appro-
priate procedures in Chapter 3.
Hitchcock et al. (2007) investigated the possible benefits of pre-smoothing functional
data before performing cluster analysis. They compare the accuracy of clustering results by
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the use of unsmoothed functional data with two smoothed versions of the data and finds
that smoothing produces a more accurate clustering. In our case, we will first apply non-
parametric regression smoothing to the pulse waves and then make further analysis, such as
functional boxplots, FANOVA, permutation tests and equivalence testing.
2.1 Visualization by Functional Boxplot
To analyze functional data, researchers often used mathematical models, among which Ram-
say (2006) provided various parametric methods while Ferraty and Vieu (2006) developed
detailed nonparametric techniques. In contrast to model-based analysis, visualization meth-
ods often help to display the data, highlight their characteristics, and reveal interesting
features.
A traditional boxplot is a robust tool for visualizing univariate data, giving an assess-
ment of the symmetry of the data and identifying outliers. However, this method of assessing
univariate data is unable to account for the complexity of functional data where multiple
measurements are taken per observation.
When constructing a traditional boxplot, the observations are first ordered by numeric
values so that the median observation, the first and third quartiles may be found. Order-
ing multivariate and functional data is more complicated. For this reason, various methods
have been proposed to define a depth score for each multivariate and functional observation
by which the observation can be ranked. Examples of depth for multivariate observations
include the Mahalanobis depth (Mahalanobis, 1936), the Tukey halfspace location depth
(Tukey, 1975), the Oja depth (Oja, 1983), the simplicial depth (Liu et al., 1990), the major-
ity depth (Singh, 1991), and the likelihood depth (Fraiman et al., 1999).
Vardi and Zhang (2000) proposed an L1−depth which can be extended to functional
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observations. Febrero et al. (2007) reviewed the functional depth of trimmed means (Cuevas
et al., 2006; Fraiman and Muniz, 2001). Lo´pez-Pintado and Romo (2009) introduced notions
of band depth (BD) and modified band depth (MBD) as ways to order functional data. They
allow for ordering a sample of curves from the center outward and, thus, introduce a measure
to define functional quantiles and the centrality or outlyingness of a functional observation.
Having the order of curves, the functional boxplot is a natural extension of the classical
boxplot and is an informative and appealing tool for visualizing functional data. BD is the
proportion of a functional observation, i.e., a curve, that falls within a band delimited by
two functional observations. Considering a data set with N functional observations, there
are
(
N
2
)
= N(N−1)
2
possible number of bands catching a single functional observation. BD for
a single curve is the ratio of the sum of the number of bands containing this target curve to
the total number of possible bands.
Figure 2.1 shows a simple example with four curves on how to compute BD and MBD
in practice. First, there are six possible bands delimited by two curves. For example, the
gray area in Figure 2.1 is the band delimited by y1(t) and y3(t). We notice that the curve
y2(t) falls completely within the band, while y4(t) only partly does. We define that a curve
is contained in a band if this curve is on the border of the band. Then the band depth
for the curve y2(t) is 5/6 = 0.83 since only the band delimited by y3(t) and y4(t) does not
completely contain the curve y2(t) and the band depth for the curve y4(t) is 3/6 = 0.5 as
it only falls completely within the band delimited by itself and another curve. Similarly,
we could compute BD(y1) = 0.5 and BD(y3) = 0.5. To compute MBD, we see that the
curve y2(t) is always contained in the five bands, hence MBD(y2) = 0.83, the same value
as BD. In contrast, the curve y4(t) only belongs to the band in gray 40% of the time, thus
MBD(y4) = (3 + 0.4 + 0.4)/6 = 0.63 by definition. The median curve is the one with the
largest BD or MBD score. Sun and Genton (2012) used both the BD and MBD to create
functional boxplot.
In the classical boxplot, the box itself represents the middle 50% of the data. While
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Figure 2.1: An example of BD and MBD computation: the gray area is the band delimited
by y1(t) and y3(t). The curve y2(t) completely belongs to the band, but y4(t) only partly does.
Graph from Sun and Genton (2012).
in the functional boxplot, the band delimited by the α proportion (0 < α < 1) of deepest
curves from the sample is used to estimate the α central region. In particular, the sample
50% central region is
C0.5 = {(t, y(t)) : min
r=1,··· ,dn/2e
y[r](t) ≤ y(t) ≤ max
r=1,··· ,dn/2e
y[r](t)},
where dn/2e is the smallest integer not less than n/2, and y[i](t) denotes the sample curve
associated with the ith largest band depth value at time t. We view y[1](t), · · · , y[n](t) as
order statistics, with y[1](t) being the deepest (most central) curve or simply the median
curve, and y[n](t) being the most outlying curve. The border of the 50% central region is
defined as the envelope representing the box in a classical boxplot. Thus, this 50% central
region is analogous to the ”interquartile range” (IQR) and gives a useful indication of the
spread of the central 50% of the curves. We extend the 1.5 times IQR empirical outlier
criterion to the functional boxplot. The fences are obtained by inflating the envelope of the
50% central region by 1.5 times the range of the 50% central region. Any curves outside the
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fences are flagged as potential outliers.
We made functional boxplots for the waveforms of each person to get an overall idea of
the behavior of curves. One issue regarding the pulse waves is that several waveforms do
not seem to start at the right place due to the difficulty in the determination of minimum
local points and separating individual cycles during the data preprocessing. We also used
functional boxplots to edit the curves: identifying the proper starting points of each curve.
However, to make the boxplots for the curves, the data format needs to be a p × n matrix
where n is the number of curves, and p is the number of evaluation points for each curve.
However, the length of each pulse wave in our dataset varies from 0.6 seconds to 1.1 sec-
onds. Therefore, we first applied the kernel smoothing to the full-length curves, and then
truncated the smoothed curves to get equal-length pulse waves. After that, the functional
boxplots can be obtained using the fbplot function in R package fda (Ramsay et al., 2015).
Figure 2.2 shows the functional boxplots for person 1, person 2, person 7, and person 10.
The dark-colored areas represent the 50% central regions for each of the four persons with
the median curves shown in black. The red dashed lines indicate possible outliers. There
are three outliers (curves 16, 33, 54) for person 1; one outlier (curve 83) for person 2; three
outliers (curves 4, 5, 88) for person 7; four outliers (curves 1, 2, 5, 54) for person 10.
We noticed that, for example, curve 83 of person 2 was an outlier. However, it seemed
to start at an inappropriate place and the beginning of the curve may be the tail of the
previous one. If we shift this outlier to the left and make it start at a more reasonable
point, it may fall within the “interquartile range” and no longer be an outlier. We found the
most appropriate beginning and end points of each outlier or improperly behaved curves for
person 1, person 2, person 7 and person 10. Figure 2.3 shows the corresponding functional
boxplots using the smoothed and shifted data for these four people. We observed that curve
83, after moving to a more proper beginning point, was no longer an outlier. We identified
the outlier curves from the functional boxplots and cleaned the data by shifting outliers to a
more proper starting point. From Figure 2.3, we can see that these four persons have similar
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Figure 2.2: Functional boxplots for person 1, 2, 7, and 10. The colored area represents
the 50% central region, with the median curve shown in black. The red dashed lines indicate
possible outliers.
overall pulse wave patterns; however, person 1 and person 10 have a more apparent dicrotic
notch than person 2 and person 7. Person 2 has a much lower systolic amplitude and thus
was less steep than the other three.
Since the lengths of the curves vary, we also rescaled the time variable on the horizontal
axis to a (0, 1) scale so that each curve has the same length. The formula used is
t
′
=
t−min t
max t−min t
where t is the original value and t
′
is the normalized value. Figure 2.4 (a) shows the functional
boxplot for Person 1 after smoothing and shifting on original curves, and (b) represents the
functional boxplot for Person 1 after smoothing and shifting on curves rescaled to (0, 1) on
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Figure 2.3: Functional boxplots for person 1, 2, 7, and 10 using smoothed and shifted data.
time scale. The overall shape of the functional boxplot does not change much. Also note
that, for the rescaled data, we can compare relative locations of various features such as the
systolic peak or dicrotic notch across subjects.
2.2 Functional ANOVA to Differentiate Persons
Analysis of variance (ANOVA) is a statistical technique that examines differences in the
means of a variable across groups of observations. Frequently, we use ANOVA to test for dif-
ferences among several means by comparing variability among groups relative to variability
within groups. We reject the null hypothesis of equality if the between-subject variability is
much greater than the within-subject variability. For functional data, the problem of test-
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Figure 2.4: Functional boxplots for person 1 after smoothing. (a): smoothing on original
curves; (b): smoothing on curves rescaled to (0, 1) on time scale.
ing the null hypothesis of equality of their respective mean functions given k independent
samples is considered. Functional ANOVA models partition a functional response according
to the main effects and interactions of various factors and are appropriate when the data
consists of functions that are expected to differ according to some set of categorical factors
(Ramsay, 2006). Thus, the setting is quite similar to that of classical one-way ANOVA model
except for the k samples under study consist of functional data.
Let Yij(t), j = 1, 2, · · · , ni, t ∈ [a, b] be k independent samples from L2-processes Yi, i =
1, 2, · · · , k, such that E(Yij(t)) = fi(t). We want to test the null hypothesis of
H0 : f1(·) = f2(·) = · · · = fk(·).
Fan and Lin (1998) considered the case when the sampling information is in a “discrete”
format Yij(t), t = 1, · · · , T . They proposed a HANOVA (high dimensional ANOVA) test
which relies on wavelet thresholding techniques. Maldonado et al. (2002) used a method
based on permutation distributions and provided an example in neurophysiology. Kaufman
et al. (2010) developed a general framework for functional ANOVA modeling from a Bayesian
viewpoint assuming Gaussian Process prior distributions for each batch of functional effects.
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They further assumed that the covariance between errors can be specified as a member of
Mate´rn covariance functions.
Cuevas et al. (2004) proposed a simple natural test for one-way ANOVA model for func-
tional data. The test procedure can be seen as an asymptotic version of the well-known
F-test, and the test statistic is given by
Vn =
∑
i<j
ni||Y¯i. − Y¯j.||2,
where Y¯i. = Y¯i.(t) =
∑ni
j=1
Yij(t)
ni
, Yij(t) represents the observed value from the j
th curve of
the ith subject at time t, ni is the number of functional observations for subject i, and || · ||
stands for the usual L2 norm, ||y|| =
√∫ b
a
y2(t)dt.
The asymptotic distribution of Vn under H0 is linear combinations of independent Gaus-
sian processes. Provided that ni are large enough, null hypothesis is rejected at a level of α,
whenever Vn > Vα, where PH0(Vn > Vα) = α. Then an asymptotic Monte Carlo procedure
is implemented to approximately evaluate Vα. The test can be easily carried out using the
function anova.onefactor in R package fda.usc (Bande and de la Fuente, 2016). Figure
2.5 and 2.6 show the functional ANOVA based on 1000 bootstrap resamples for comparing
Person 1, 2, 7, 10, 11, and 14 using the truncated and rescaled curves after smoothing and
shifting the outliers. The p-values for comparison among six persons using either the trun-
cated or rescaled curves are 0’s, indicating that at least one person has different underlying
waveform from the others. Person 1 (red) behaves like Person 7 (blue) regarding functional
mean, so we performed the functional ANOVA comparing these two individuals in Figure
2.7 after shifting and truncating. There are 15 pairwise comparisons for a small group of six
persons. Therefore, with the Bonferroni correction, we test each individual hypothesis at a
significance level of α/15, where α is the desired overall significance level. The test statistic
for comparing between Person 1 and Person 7 is 1063.419 with a p-value of 0.061 after the
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Figure 2.5: Functional analysis of variance for six persons. A p-value of 0 indicates a
significant difference among 6 individuals.
Bonferroni correction. Therefore, we do not have enough evidence to differentiate these two
people from their underlying waveforms at 5% overall significance level.
Figure 2.6: Functional analysis of variance for six persons using data rescaled to (0, 1) on
time scale. A p-value of 0 indicates a significant difference among 6 individuals.
We also performed functional ANOVA on another small group of four people (Person 3, 6,
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Figure 2.7: Functional analysis of variance for comparing Person 1 and Person 7. A
p-value of 0.061 shows that we do not have enough evidence to differentiate these two people.
8, and 12) in the sample, and significantly different underlying waveforms could be detected
for all the comparisons we made. Therefore, we feel reasonably confident that the variability
among curves of different people is great enough, relative to the variability of curves within
people, to use these curves for authentication.
2.3 Permutation Test for Functional Data
Another way in which we assess the appropriateness of this data for authentication is permu-
tation tests, an approach for carrying out non-parametric tests. Permutation tests are most
useful when we have insufficient information about that distribution of the response variable,
are uncomfortable making assumptions about the distribution, or if the distribution of the
test statistic is not easily computed or derived. In our case, pulse wave data itself is complex,
and the distribution of the test statistic is difficult to derive. Thus, the permutation test is
an option to have a general idea on the behavior of the waveforms.
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In our case, we will employ a permutation test in which the distribution of the test
statistic under the null hypothesis is obtained by calculating all possible values of the test
statistic under rearrangements of the labels on the observed data. In contrast to many popu-
lar “classical” statistical tests, such as the t-test, F-test, z-test, and χ2-test, whose reference
distributions are obtained from theoretical probability distributions, permutation tests build
the reference distribution by resampling the observed data. Like bootstrapping, a permu-
tation test does not rely on traditional distribution assumptions and the only assumption
required is that the samples are assumed to be independent.
In each iteration of a permutation test, we rearrange the data set and compute the test
statistic from the shuffled data. The proportion of the shuffled test statistics that are as
extreme and more extreme than the observed test statistic gives a p-value. While a per-
mutation test requires that we perform all possible permutations of the data, which can
become quite large, we can efficiently conduct approximate permutation tests by conducting
a large number of random resamples. That process should, in expectation, approximate the
permutation distribution.
For our project, we first performed the permutation test on four persons (person 1, 2, 7
and 10) to see if they share the same population mean waveform. There are 57 curves for
person 1, 89 curves for person 2, 92 curves for person 7, and 56 curves for person 10. The
null and alternative hypotheses for the test can be stated as follows:
H0 : Four persons have identical mean waveform.
Ha : At least one person has different mean waveform from the others.
We selected the middle 40 curves from each of the four persons since curves in the middle
part of the data collection process were more stable and reliable than those from the begin-
ning and the tail. A nonparametric regression estimate using local polynomial kernel GEE
method (Chapter 4 of Wu and Zhang (2006)) was obtained by applying kernel smoothing to
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the full-length curves before making further analysis.
We consider the area between two estimated curves as our test statistic, and we compute
it from the trapezoidal rule. The trapezoidal rule is a technique for approximating the
definite integral
∫ b
a
f(t)dt. The trapezoid rule works by approximating the region under the
graph of the function f(t) as many trapezoids and calculating the sum of their areas. Let
tk be a partition of [a, b] such that a = t0 < t1 < t2 < · · · < tN−1 < tN = b and ∆tk be the
length of the kth subinterval, that is, ∆tk = tk − tk−1. Then
∫ b
a
f(t)dt ≈ TN =
N∑
k=1
f(tk−1) + f(tk)
2
∆tk. (2.1)
Since the time points are equally-spaced after smoothing, ∆tk = ∆t is a constant. The
approximation becomes more accurate as the resolution of the partition N increases.
Let C1(t), C2(t), C7(t) and C10(t) represent the local linear regression estimates from each
person, and C˜(t) is the estimated curve using local linear regression based on all 120 curves.
Let fi(tk) = Ci(tk)− C˜(tk), where i = 1, 2, 7, 10. Therefore, the test statistic can be written
as
T =
∆t
2
∑
i
∑
k
|fi(tk−1)|+ |fi(tk)|
= 790.824
We performed 1000 random rearrangements or shuffles in the permutation test, and none
of the test statistics from permutation is larger than the observed test statistic T = 790.824.
Thus, the probability of obtaining results as or more extreme than the observed test statistic
T in this set is zero. In another words, the permutation p-value is approximately 0. Thus, at
least one person has a different underlying waveform from the others at 5% significance level.
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P-value Person 1 Person 2 Person 7 Person 10
Person 1 – 0 0.002 0.001
Person 2 – 0 0
Person 7 – 0
Person 10 –
Table 2.1: Permutation p-values for comparing between two individuals using a Bonferroni
adjustment.
Next, we continue to make pairwise comparisons. The permutation p-values for pairwise
comparisons among Person 1, 2, 7, and 10 using a Bonferroni adjustment are shown in Table
2.1. All of the p-values are significant at 5% significance level. Thus, we can successfully
differentiate between any pair among these four people.
Pulse waves collected at a different times of the day from the same person may not have
an identical mean pattern. Permutation tests can also be used to test if curves from the same
individual have different underlying waveforms. We consider smoothed and shifted data for
the permutation test for person 1. The first 30 curves are grouped as the training data and
the rest 27 curves as the test data. The area computed from trapezoidal rule between the two
estimated curves from training and test set is 46.758. We used 1000 random permutations
and computed the area between two groups from the trapezoidal rule. We found that 530
test statistics out of 1000 are bigger than 46.75847. Thus, the two-sided p-value is 0.53.
The p-value for comparison within Person 1 using curves rescaled to (0, 1) on timescale
is 0.566. At 5% significance level, there is no evidence to conclude that training and test
from Person 1, using either original pulse waves or waves rescaled to (0, 1) on timescale, have
different probability distributions. We performed the same procedure on Person 2, 7, and 10.
The results are shown in Table 2.2. We obtained non-significant results for within-subject
comparisons on Person 1, 7, and 10. That is to say, if we have two groups of pulse waves
from each of these three people, we do not have enough evidence to distinguish between
training and test sets. At 5% significance level, the p-value for comparison within person
2 is significant. One of the possible reasons is that the pulse wave data is collected at K-
30
Within a person Original curves Rescale on time
Person 1 0.53 0.566
Person 2 0.001 0.05
Person 7 0.32 0.388
Person 10 0.187 0.156
Table 2.2: Permutation p-values for comparing within a person using original curves, and
curves rescaled to (0, 1) on time scale.
state Open House. Thus, subject may have been excited and not quite calmed down at the
beginning of the data collecting process resulting in different behavior occurred between the
early and late parts of the waveforms.
2.4 Summary
In this chapter, we visualized and explored the pulse waves by looking at the functional
boxplots. We also used functional boxplots to correct outliers and shift them back to a
more proper starting point. FANOVA and permutation test can quickly and accurately
differentiate people if the pulse waves do not belong to the same person. However, the
primary goal of identity authentication is still not achieved due to the nature of traditional
hypothesis testing because a non-significant test for the difference is not the same as the
proof of similarity. In the next chapter, we introduce equivalence testing that could be used
to confirm a person’s identity, i.e. the pulse waves are actually from the same person. An
equivalence test aims to establish equivalence by rejecting a null hypothesis which states that
a meaningful difference exists. It is a statistical test of hypotheses for which the inferential
goal is to provide evidence of practical equivalence rather than declare a significant difference.
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Chapter 3
Equivalence Testing for Identity
Authentication
From Chapter 2, we are reasonably confident that the variability among curves between
different people is large enough, relative to the variability among curves within a person, to
use these curves for authentication. However, the goal of identity authentication is still not
achieved by either the FANOVA or the permutation test. In this chapter, we employ the
content of equivalence testing and propose a new testing procedure to confirm the identity.
We first give an introduction to equivalence testing in Section 3.1.1 and then explain why
we have chosen an equivalence test for identity authentication in Section 3.1.2. Equivalence
testing is commonly used in the approval process for generic drugs; thus in Section 3.2
we introduce the assessment of bioequivalence (BE) of two drugs using the two one-sided
test procedure (TOST), the most common statistical method for validating equivalence.
We also review guidelines for choosing the equivalence bands (EB) suggested by FDA. In
Section 3.3.2, we propose a new testing procedure, the nonparametric bootstrap functional
equivalence test (NBFET) which could be implemented to evaluate equivalence for functional
data.
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3.1 Equivalence Test
Ideally, scientists should be able to provide evidence for the absence of a meaningful effect.
Currently, researchers often conclude an effect is absent based on a nonsignificant test for
difference. Unfortunately, the logic of this approach is flawed; non-significance does not
provide evidence that the null hypothesis is true. A widely recommended alternative within
a frequentist framework is to test for equivalence. An equivalence test aims to establish
equivalence by statistically rejecting a null hypothesis which states that a meaningful differ-
ence exists. Equivalence testing originates from the field of pharmacokinetics (Hauck and
Anderson, 1984), where researchers sometimes want to show that a generic version of an
existing drug or “pioneer” has, to a practical extent, the same pharmacokinetic properties as
the pioneer; therefore, the generic drug can be prescribed to patients in place of the pioneer
drug.
3.1.1 What is an equivalence test?
An equivalence test is a statistical test of hypotheses for which the inferential goal is to estab-
lish practical equivalence rather than declare a statistically significant difference (Berger and
Hsu, 1996). For example, we can use an equivalence test to determine whether the means
for two groups of measurements are close enough to be considered equivalent. The term
“equivalence” is employed here to denote a weaker, or fuzzy, form of an identity relation.
The fuzziness of the equivalence hypotheses comes from the fact that exact equality is not
required to establish equivalence. Rather, the hypothesis of zero difference, corresponding to
the null hypothesis of the traditional two-sided testing problem, is expanded into an interval
or “indifference zone” (Wellek, 2010). Differences between two treatments small enough to
fall into this interval are deemed equivalent for practical purposes. For example, a deviation
of 1 or 2 mg from a targeted 200 mg dose of a drug may be unlikely to have any practical
effect when taken by a patient.
A crucial first step in performing a test of equivalence is deciding which parameters to
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compare and then defining how large the difference between them must be for the difference
to be considered practically important. For example, in the case of the simple parallel group
design with two treatment arms, we may want to test whether the population means of
the reference group and the test group are close enough to be considered equivalent. For
simplicity, assume that the two groups have the same variance, i.e., σ2T = σ
2
R = σ
2. A test of
equivalence may be based on the difference of the two means, µT − µR. Equivalence of the
two groups could be concluded if we can demonstrate that the difference between the two
means is small, i.e.,
−l < µT − µR < u,
where l and u are some small non-negative known constants. The interval (−l, u) would
define our zone of indifference, and the values −l and u are then referred to as equivalence
limits. The actual, numerical values of the equivalence limits must be assigned a priori, i.e.,
without knowledge of the data. As the guidance for bioequivalence studies, the United State
Food and Drug Administration (FDA) recommended using the specifications ±20% of the
reference mean as the equivalence limits.
Examples of scenarios requiring equivalence tests include the assessment of a generic drug
performance relative to a brand-name drug and a comparison study in which the agreement
of new measurement device with the “gold standard” for measuring a particular phenomenon
must be assured before the new device can replace the old one. Recently, equivalence testing
has been growing in use in scientific research outside its traditional role in the drug approval
process and has made inroads in scientific applications unrelated to drug development (Bar-
nett et al., 2006, 2007). Barker et al. (2002) propose to use equivalence test for measuring
disparities in vaccination coverage, and Tempelman (2004) applies bioequivalence hypothesis
testing to dairy nutrition studies. Parkhurst (2001) states that “equivalence tests improve
the logic of significance testing when demonstrating similarity is important.”
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3.1.2 Why use an equivalence test?
In the usual two-sample two-sided hypothesis test, also called a test of difference, the null
hypothesis is that the two experimental groups under study do not differ with respect to a
particular parameter, e.g., the mean. If the analysis reveals a statistically significant differ-
ence between groups, the null hypothesis of no difference is rejected, and the two groups are
then declared to be different. If the analysis fails to indicate that a statistically significant
difference between groups exists, the null hypothesis cannot be rejected. However, failing
to find a difference is not the same as a proof of similarity. Non-significance may be due
to having a sample size that is too small to detect the true difference. The result of non-
significance has a history being misinterpreted in some research (Farrington and Manning,
1990; Huh, 1994; Westlake, 1981). Psychologists have incorrectly concluded there is no effect
based on a non-significant test result. For example, the word ”no effect” has been used in
108 articles published in Social Psychological and Personality Science up to August 2016.
Manual inspection revealed that the conclusion of ”no effect” was based on statistical non-
significance in almost all of these articles. Finch et al. (2001) reported that in the Journal of
Applied Psychology, an average of around 38% of articles with nonsignificant results makes
a conclusion that accepts the null hypothesis. This practice is therefore problematic. If the
researcher truly wants to be able to claim that the two groups are statistically ”similar,” it
is not enough to perform a two-sided test of difference and ”not reject” the null hypothesis
since failing to reject a null hypothesis of no difference is not logically equivalent to providing
evidence for a claim equivalence. As Altman and Bland (1995) put it: ”absence of evidence
is not evidence of absence.”
One critical objective in the present work is to show that the pulse waves being tested
do in fact belong to the person owning the sensor. Because the mistake of claiming the
wrong person is worse than failing to identify the correct person, it is important to deter-
mine whether a person’s curves are unique enough to be used for authentication. In other
words, our inferential goal is to establish practical similarity rather than detect a statisti-
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cally significant difference. Therefore, we consider a test of equivalence where the alternative
hypothesis of similarity is supported by rejecting the null hypothesis of difference.
3.2 The Assessment of Bioequivalence
Two different formulations of the same drug are said to be bioequivalent if they are absorbed
into the blood and become available at the drug’s site of action at about the same rate and
concentration. The determination of bioequivalence (BE) is crucial because the approval of
generic drugs in the United States often requires the establishment of bioequivalence between
the name brand drug and the proposed generic drug. If the manufacturer of the generic drug
can demonstrate BE, it can avoid performing costly clinical trials to prove the safety and
efficiency of its generic drug.
In many bioequivalence studies, the concentration of the active ingredient of interest is
measured in the blood plasma or serum over time. These concentration/time measurements
can be connected with a curve, and several variables can be observed. Figure 3.1 shows an
example of the concentration-time profile of two drugs. Instead of analyzing the individual
profile as multivariate or functional data, the profile is usually reduced to a small number of
real values by computing one or more of the following pharmacokinetic characteristics:
• area under the curve as a whole (AUC),
• maximum concentration (Cmax), and
• time at which the peak concentration Cmax was measured (tmax).
The two drugs are bioequivalent if the population means of these variables are sufficiently
close. Commonly, AUC and Cmax are considered as alternative estimates of the extent of
the absorption process for a trial subject, whereas tmax is interpreted as a measure of rate.
All three parameters are considered as a reasonable option for a reference measure of bioe-
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Figure 3.1: Example of concentration-time profiles for drug A and drug B. Birkett (2003).
quivalence.
For example, let µT denote the population mean AUC for the generic (Test) drug and
µR denote the population mean AUC for the name brand (Reference) drug. To demonstrate
bioequivalence, the following hypotheses are tested:
H0 :
µT
µR
≥ θU or µT
µR
≤ θL
Ha : θL <
µT
µR
< θU .
The values of θL and θU are specified by the researchers and define how ”close” the versions
of the drug must be to be declared bioequivalent. Here, the interval (θL, θU) presents the
zone of indifference. Currently, both FDA (1992) and the European Community (EC, 1993)
use θL = 0.8 and θU = 1.25, values that are symmetric in the ratio scale, i.e. 1/0.8 = 1.25.
Commonly, natural logarithms of the AUC values are computed before analysis so that
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more appropriate hypotheses are:
H0 : ηT − ηR ≥ U or ηT − ηR ≤ L
Ha : L < ηT − ηR < R
where ηT = log(µT ), ηR = log(µR), L = log(θL), U = log(θU). With θL = 0.8, θU = 1.25,
U = −L, the standards are symmetric. The Type I error rate is the probability of claiming
the drugs to be bioequivalent, when in fact they are not. By setting up the hypotheses above
and controlling the Type I error rate at a specified small value, say, α = 0.05, the consumer’s
risk is being controlled.
3.2.1 Equivalence Tests for Differences Between Two Independent
Means
The formulation of equivalence hypotheses leads to the most basic form of equivalence test-
ing, the two one-sided tests (TOST) procedure (Barker et al., 2001; Berger and Hsu, 1996;
Huh, 1994; Schuirmann, 1987). Largely due to its ease of use and recommendations from
FDA guidance, the TOST procedure is the most common statistical method for testing
equivalence. The goal in the TOST approach is to specify a lower and upper bound, such
that the results falling within this ranges are declared equivalent. As the name implies, the
TOST is a two-step procedure and consists of decomposing the interval hypothesis H0 and
Ha above into two sets of one-sided hypotheses. For example, the hypotheses of equivalence
testing for differences between two independent means are set up as follows:
H01 : ηT − ηR ≥ U
Ha1 : ηT − ηR < U ,
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and
H02 : ηT − ηR ≤ L
Ha2 : ηT − ηR > L.
For each pair of hypotheses, a test statistics is computed and then compared to a critical
value from the t distribution. Specifically, H01 is rejected if
y¯T − y¯R − U
s
√
1
nT
+ 1
nR
< −tα,r,
and H02 is rejected if
y¯T − y¯R − L
s
√
1
nT
+ 1
nR
> tα,r,
where y¯T denotes the sample mean of a random sample for the test drug from a normal
population with mean ηT and variance σ
2, and y¯R denotes the sample mean of a random
sample for the reference drug from a normal population with mean ηR and variance σ
2, nT
and nR are the sample sizes for the test and reference group, and s
2 is the pooled estimate
of variance σ2, i.e., s2 = {∑nTi=1(yi− y¯T )2 +∑nRj=1(yj − y¯R)2}/(nT + nR − 2). Here, tα,r is the
upper 100α percentile of a t distribution with r = nT + nR − 2 degrees of freedom.
These equations are highly similar to the familiar Student’s t-statistic for traditional,
one-sided tests of statistical significance with the only difference being that the lower equiva-
lence bound L and the upper equivalence bound U are subtracted from the mean difference
between groups. If we successfully reject the null for both tests, practical equivalence may
then be asserted at the 100α% significance level; otherwise, we fail to reject the assumption
of a practical difference.
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3.2.2 Confidence Interval Approach to Equivalence Testing
The TOST procedure is also identical to forming the corresponding (1 − 2α)100% confi-
dence interval and declaring the two groups equivalent if the interval lies entirely within
the tolerance limits (L, U). The reason the confidence level is (1 − 2α)100% and not the
usual (1−α)100% is because this method is equivalent to performing two separate one-sided
level-α tests. A careful explanation can be found in Berger and Hsu (1996) and Barker et al.
(2001). Thus, a 90% confidence interval yields a 5% significance level for testing equivalence.
Both FDA (1992) and EC (1993) specify that the TOST should be executed in this fashion.
Equivalence for differences between two independent means shown in the previous section
will be declared if the lower confidence bound y¯T − y¯R− tα,rs
√
1/nT + 1/nR is above L and
the upper confidence bound y¯T − y¯R + tα,rs
√
1/nT + 1/nR is below U .
When both the tests of difference and equivalence tests are used, there will be four pos-
sible outcomes in the confidence interval procedure: the effect is statistically equivalent and
not statistically different from zero (Scenario A), statistically equivalent and statistically dif-
ferent from zero (Scenario B), statistically different from zero but not statistically equivalent
(Scenario C), or neither statistically different from zero nor statistically equivalent (Scenario
D). In Figure 3.2, mean differences (black dots) and their 90% (thick lines with arrows) and
95% (thin lines) confidence intervals are illustrated for the four scenarios. The equivalence
limits chosen here are L = −0.3 and U = 0.5.
To conclude equivalence (Scenario A and B), the 90% CI around the observed mean
difference should fall within the equivalence bands (L, U) = (−0.3, 0.5). The traditional
two-sided test of difference is rejected (Scenario C) when the CI for the mean difference does
not include zero. Effects can be statistically different from zero and statistically equivalent
(Scenario B) when the 90% CI falls within the equivalence bounds and the 95% CI excludes
zero. Finally, an effect can be neither statistically different from zero nor statistically equiv-
alent (Scenario D) when the 90% CI includes one of the equivalence bounds and the 95% CI
40
Figure 3.2: Mean differences (black dots) and 90% confidence intervals (thick blue hori-
zontal lines with arrows) and 95% confidence intervals (thin orange horizontal lines) with
equivalence bands L = −0.3 and U = 0.5 for four combinations of test results that are
statistically equivalent or not and statistically different from zero or not.
includes zero.
3.2.3 Setting Equivalence Bands
The determination of equivalence limits, L and U , is the most critical step in equivalence
testing. Large values of L and U determine a wider equivalence region and make it less
difficult to establish equivalence. The equivalence limits not only determine the results of
the test but also gives scientific credibility to the study. The value of a study or experiment
largely depends on how well the equivalence limits can be scientifically justified.
FDA and Center for Drug Evaluation and Research (CDER) recommend that statisti-
cal analysis for pharmacokinetic measures, such as AUC and Cmax, be based on the TOST
procedure to determine whether the average values for a pharmacokinetic measure observed
after administration of the Test and Reference products are comparable. This approach is
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termed average BE and involves the calculation of a 90% confidence interval for the ratio of
the averages (population geometric means) of the measures for the Test and Reference drug.
To establish average BE, the calculated confidence interval should fall within the BE limits,
usually 80%-125% for the ratio of the product averages.
For a broad range of drugs, a BE limit of 80% to 125% for the ratio of the product
averages has been adopted for the use of an average BE criterion. Generally, this limit of
80%-125% is based on a clinical judgment that a test product with measures outside this
range should be denied market access. However, for highly variable drugs, defined as those
for which the within-subject variability equals or exceeds 30% of the mean Cmax and/or
AUC, the equivalence limits may be widened to 0.75 -1.33 or even 0.70-1.43 (Midha et al.,
2005). We will discuss the procedure of determining appropriate equivalence bands for our
study in Section 4.4.
3.3 Equivalence Testing for Functional Data
Equivalence testing for scalar data has been well-addressed in the literature. However, the
same cannot be said for functional data. The complication from keeping the functional
structure of the data, rather than using a scalar transformation to reduce dimensionality,
makes the existing literature on equivalence testing deficient for the desired inference on
pulse waveforms. In this work, a framework for functional equivalence testing that is analo-
gous to its univariate counterpart is proposed and evaluated.
3.3.1 TOST for Functional Data
A TOST procedure is a commonly used approach for conducting the hypothesis testing
within the frequentist paradigm. Brown et al. (1997) and Berger and Hsu (1996) propose
procedures which are uniformly more powerful for the scalar data since the TOST procedure
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can suffer from a lack of power. However, these methods are themselves quite complicated
even for univariate data, and their added complexity does not seem to be justified by their
relatively small gain the power (Meyners, 2012). For this reason, in the majority of appli-
cations, TOST continues to be the method of choice extended to the equivalence testing for
functional data within the frequentist paradigm.
In the functional data setting, let θ(·) denote a functional measurement of similarity be-
tween the location parameters of two functions. One potential choice for θ(·) is the difference
between overall mean functions, µ1(·) − µ2(·). Let κl(·) and κu(·) denote lower and upper
equivalence limits which are now functions. These bands are chosen such that practical
equivalence can be established depending on whether or not θ(·) falls entirely within the
equivalence bands defined by κl(·) and κu(·). The null and alternative hypotheses for the
tests of location can be stated as follows:
Hθ0 : ∃t ∈ T , θ(t) /∈ (κl(t), κu(t)),
Hθa : ∀t ∈ T , θ(t) ∈ (κl(t), κu(t)).
Note that the above test, in aggregate, is an Intersection-Union Test (IUT)(Berger and Hsu,
1996). To test these hypotheses within the frequentist paradigm, we can conduct TOST
procedures for the location parameter θ(·). Since this is an IUT, each of the hypothesis tests
can be conducted at significance level α to arrive at an overall size of α. In practice, func-
tional data are measured along a finite grid of values. Thus, the grid must be fine enough
so that areas of potential dissimilarity along the domain are not ignored.
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3.3.2 Nonparametric Bootstrap Functional Equivalence Test
Fogarty and Small (2014) proposed using the nonparametric bootstrap of Efron and Tib-
shirani (1994) for assessing equivalence by constructing point-wise confidence intervals for
the metric of equivalence and then using the duality between confidence intervals and point-
wise hypothesis tests to conduct the inference. We modified the nonparametric bootstrap
approach and applied it to the simulated data. If we consider two sets of curves generated
from the same person, then equivalence should be concluded since these two sets share the
same population mean.
We define the first set of curves as the reference group, and the second set of curves as
the test group. Let µR(t) denotes the population mean curve for the reference group and
µT (t) denote the population mean curve for the test group. Consider the ratio of two mean
curves as a metric for equivalence and then conduct the following hypotheses:
H0 :
µT (t)
µR(t)
≥ θu or µT (t)
µR(t)
≤ θl for some t
Ha : θl ≤ µT (t)
µR(t)
≤ θu for all t
The values of θl and θu are specified by the researcher and define how close the mean curves
must be to be declared equivalent. We might choose θl = 0.8 and θu = 1.25 as the equivalence
limits as suggested by the FDA guidance on BE. If we can show that the ratio of two curves
falls within the range of (θl, θu), the underlying mean curves are declared to be equivalent.
Let yˆR(·) and yˆT (·) denote the nonparametric regression estimates of repeated measurement
curves for the reference group and test group, respectively. We use
T (·) = yˆT (·)
yˆR(·)
as test statistics for the hypothesis and apply the nonparametric bootstrap procedure to de-
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rive point-wise confidence intervals. The duality between one-sided confidence intervals and
one-sided tests helps to decide to reject or fail to reject the difference of the null hypothesis.
Let yRi(t) be the i
th curve for the reference group, i = 1, 2, · · · , nR, and yT i(t) be the ith curve
for the test group, i = 1, 2, · · · , nT . We compute the sample averages for both the reference
and the test group at each time points y¯R(t) =
1
nR
∑nR
i=1 yRi(t) and y¯T (t) =
1
nT
∑nT
i=1 yT i(t).
In each iteration, we do the following:
1. Sample nR curves with replacement from the reference group, and sample nT curves
with replacement from the test group.
2. Compute nonparametric regression estimates of the repeated measurements curves for
the reference and test group using the sm.rm function from R package sm (Bowman and
Azzalini, 2015). Denote these as {yˆ∗R(·)} and {yˆ∗T (·)}. We compute yˆ∗R(·) = S∗Ry¯∗R(·) and
yˆ∗T (·) = S∗T y¯∗T (·), where y¯∗R(·) and y¯∗T (·) are the sample average curves, and S∗R and S∗T are
the smoothing matrices depending on the smoothing parameter for the reference and the
test group, respectively. Hart and Wehrly (1986) proposed a criterion for the choice of the
smoothing parameter in the context of repeated measurements.
3. Compute Tˆ ∗(·) = yˆ∗T (·)
yˆ∗R(·) .
4. Store this value.
We perform N iterations as shown above and record the bootstrap test statistics Tˆ ∗(·).
The upper and lower point-wise confidence intervals for T (t) using a bias correcting percentile-
based bootstrap as discussed in Davison and Hinkley (1997) is:
Cu1−α(T (t)) = [2Tˆ (t)− qα[Tˆ ∗(t)],∞),
C l1−α(T (t)) = (−∞, 2Tˆ (t)− q1−α[Tˆ ∗(t)]),
where Tˆ (t) is the observed test statistic and qα[Tˆ
∗(t)] is the αth percentile of Tˆ ∗(t) we
computed from step 3 in each iteration. If our lower equivalence limit at time t, θl, is
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outside of Cu1−α(T (t)), then we can reject the null that T (t) < θl(t) at point t. Likewise,
if θu(t), is outside of C
l
1−α(T (t)), we reject the null of T (t) > θu(t) at point t. The final
equivalence can be declared if we successfully reject both tests at every time point t. We call
this nonparametric bootstrap procedure the nonparametric bootstrap functional equivalence
test (NBFET) and apply it to the simulated data in Chapter 4 to verify its validity and
efficiency.
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Chapter 4
Development of Equivalence Bands
and Method Validation
Having proposed the NBFET procedure in the previous chapter, we now proceed to evaluate
the performance of the proposed testing procedure on the simulated data. We also use our
simulations as a way to determine the equivalence bands that vary based on the coefficient
of variation (CV). We present the details of our evaluation based on equivalence testing,
including the choice of the data generating process, the determination of equivalence bands,
the evaluation methodology and the simulation results.
This chapter is organized as follows, in Section 4.1 we give the rationale for using sim-
ulation to carry out our evaluation, followed by the justification of the selection of data
generating process. We then apply NBFET discussed in Chapter 3 to the simulated data
based on common choices of equivalence bands in the drug approval processes in Section
4.3. In Section 4.4, we determine the equivalence bands appropriate for our study from
the simulation results. Then, we apply NBFET procedure to simulated data based on the
chosen equivalence bands, and we conclude with a discussion in Section 4.5. In Section 4.6,
we perform equivalence testing on a small set of feature points to see whether the procedure
can be simplified but also reach the same conclusion.
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4.1 Purpose of Simulation
For our project, we have appropriate and well-behaved data from only four persons. More-
over, there is a lot of variability and inaccuracy at the beginning of the curves due to the
difficulty of separating each pulse wave cycles. By observing simulated outcomes, we can
gain insight into the behavior of real-life pulse waves without subjecting a large number of
volunteers to repeated collection of their pulse waves. If the methodology works well for the
simulated data, it is more likely to run for the real-life situation. The following are some
advantages simulation study will bring to our project.
• Simulation provides complete control over the environment. For example, during eval-
uation, we like to set the curves to start exactly at zero with increased variability over time.
This is easy to do with simulation.
• Simulation allows sharing the code with others. Thus, the results can be duplicated
and verified by other researchers, who may want to evaluate their own scenarios, leading to
a more complete evaluation.
• With simulation, other types of functional data can also be generated using the same
methodology and procedure. Hence, it allows for setting up a better and more meaningful
evaluation schema.
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4.2 Generating Simulated Functional Data using Brow-
nian Motion
In this section, we introduce how to generate the pulse wave behavior-like curves from the
Brownian motion (Hida, 1980) for use in the simulation. Brownian motion was proposed to
describe the random movement of particles in a fluid due to their collisions with other fast-
moving molecules in the fluid. Brownian motion is also known as pedesis, which comes from
the Greek word for “leaping”. Most examples of Brownian motion are transport processes
that are also affected by larger currents, such as the motion of pollen grain on still water,
movement of dust motes in a room, diffusion of calcium through bones.
Definition 1. A stochastic process {X(t), t ≥ 0} is said to be a Brownian motion process if
(i) X(0)=0;
(ii) {X(t), t ≥ 0} has stationary and independent increments;
(iii) for every t > 0, X(t) is normally distributed with mean 0 and variance σ2t.
From the definition of the Brownian motion, we can see that the process always starts
at zero, and for every time point t, it follows a normal distribution with mean zero and a
variance which is a linear function of t. Thus, there is smaller variability at the beginning of
the curves and more considerable variability at the tail. Those are features we observe from
PPG pulse waves. Therefore, we propose to simulate curves that mimic the behavior of pulse
waves from Brownian motion with a known underlying population mean. A mathematical
model that describes Brownian motion is the Wiener process, a continuous-time stochastic
process named in honor of Norbert Wiener. It has been widely used in math, economics,
engineering, physics, biology, chemistry, etc.
Definition 2. A stochastic process {X(t), t ≥ 0} is said to be a Brownian motion process
with drift coefficient µ and variance parameter σ2 if
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Figure 4.1: (a) A simulated curve from the Brownian motion with mean 500f(t; 2.1, 12) +
550f(t; 4, 5) and variance 40 , (b) a group of 50 simulated curves from Brownian motion
after smoothing using nonparametric regression.
(i) X(0)=0;
(ii) {X(t), t ≥ 0} has stationary and independent increments;
(iii) for every t > 0, X(t) is normally distributed with mean µt and variance σ2t.
We generate the curves from a modified version of Brownian motion with drift, where
our mean is not linear in t but a function of t. Let f(t;α, β) denote the probability den-
sity function of a Beta distribution with shape parameters α and β, where 0 ≤ t ≤ 1 and
α, β > 0. Figure 4.1 (a) shows a simulated curve from the Brownian motion with mean
500f(t; 2.1, 12) + 550f(t; 4, 5) and variance σ2 = 40 , and (b) shows a realization of 50 sim-
ulated curves after smoothing using nonparametric regression. From Figure 4.1 (b), we can
see that the simulated curves mimic the behavior of the pulse waves and have similar pat-
terns we found in real-life data after preprocessing.
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4.3 Nonparametric Bootstrap with Common Choices
of Equivalence Bands
We consider the curves generated from Brownian motion with the following means as the
simulated data :
Mean A: 500f(t; 2.1, 12) + 550f(t; 4, 5),
Mean B : 500f(t; 2.3, 12) + 460f(t; 4.04, 5.1),
Mean C : 500f(t; 2.3, 12) + 500f(t; 4, 5),
Mean D : 250f(t; 2.8, 12) + 520f(t; 2, 2),
Mean E : 270f(t; 2.7, 12) + 490f(t; 2.1, 2),
Mean F : 500f(t; 2.1, 12) + 550f(t; 3, 3),
where f(t;α, β) is defined in Section 4.2. Namely, the underlying population means are a
mixture of beta distributions. The beta probability density function is unimodal when both
shape parameters are greater than one, and we can therefore control where the mode occurs
by changing the shape parameters. However, there are two peaks in the real pulse waves.
Therefore, we simulated curves from Brownian motion with population means that are a
mixture of two beta densities where each distribution has both shape parameters greater
than one.
Figure 4.2 shows the six population means used in our simulation study. These mean
curves represent some of the situations we will encounter in real life. For example, Mean
A and Mean C as are Mean D and Mean E are quite close to each other the entire time
range; while Mean A and Mean F behave similarly near the first peak but are disparate after
the notch. Mean D and Mean E are quite different from the other curves. They also show
similar patterns we found in real pulse waves. We will apply NBFET as discussed in Section
3.3.2 to the simulated curves from Brownian motion with means shown above to measure
the equivalence.
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Figure 4.2: The underlying population means for the simulation study.
4.3.1 Equivalence Bands
Recall the assessment of bioequivalence discussed in Section 3.2, the two drugs are bioe-
quivalent if the population means of pharmacokinetic characteristics AUC, Cmax, or tmax
are sufficiently close. For example, let µT denote the population mean AUC for the generic
(Test) drug and µR denote the population mean AUC for the name brand (Reference) drug.
To demonstrate bioequivalence, the following hypotheses are tested:
H0 :
µT
µR
≥ θU or µT
µR
≤ θL
Ha : θL <
µT
µR
< θU .
The values of θL and θU are specified by the researchers and define how “close” the mean
responses of the measured characteristic from two drugs must be to be declared bioequiva-
lent. The interval (θL, θU) is called the zone of indifference or equivalence bands. According
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to the FDA, average bioequivalence is demonstrated if the 90% confidence interval of the
geometric mean ratios of the test and the reference drugs for the AUC fall completely within
limits (in %) of 80-125%. In other words, θL = 0.8 and θU = 1.25, which are symmetric in
the ratio scale.
Even though a review of more than a decade of bioequivalence data from the FDA sup-
ports the average bioequivalence criteria in approving high-quality drugs, there are some
concerns over some generic drugs that have a narrow therapeutic window such as some anti-
epileptic and anti-coagulant drugs. Many authors have criticized the one-fits-all criterion
because it does not consider the therapeutic window and variability of a drug. A highly vari-
able reference drug, which is defined as a drug with within-subject coefficient of variation
(CV) in one or more of the pharmacokinetic characteristics being 30% or larger, may not be
demonstrated to be bioequivalent even to itself in a typical cross-over study with a moderate
number of subjects (Davit et al., 2012). A review of 1010 bioequivalence studies of 180
generic drugs submitted to the FDA during 2003-2005 suggests that 31%(57/180) of those
are highly variable. Therefore, it is necessary to develop an alternative to the usual (0.8,
1.25) rule for highly variable drugs. It has been suggested by the European Agency for the
Evaluation of Medicinal Products (EMEA) that the bioequivalence bands of the 90% confi-
dence interval could be widened from 0.8-1.25 to 0.75-1.33 or even to 0.7-1.43, depending on
the within-subject CV. For our project, we will determine the equivalence bands appropriate
for different ranges of CV through a simulation study.
4.3.2 Determining the Evaluation Range
Before we determine the equivalence bands that are appropriate for our project through
simulation, we truncate the curves on the left and right, and limit our analysis on a specific
evaluation range. It would be the best if we could perform the equivalence test on the entire
(0, 1) time range; however, it causes some issues. First, each curve starts at zero and quickly
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Figure 4.3: Functional boxplot of a group of 50 curves generated from Brownian motion
with Mean 3 and variance of 40. We pick the truncation points at [0, 0.65].
increases at the beginning part. Thus, ratio of the test mean to the reference mean rapidly
goes up toward infinity early on even though the values are extremely close together. Sec-
ond, there is a lot of variability at the end of the curves, and the CVs at these points are
bigger than one. It is not very meaningful to measure the equivalence when the standard
deviation is larger than the mean. Third, some curves go below zero at the tail, and we have
negative values of the ratio of the mean curves. It is possible to have negative ratios but
not practically meaningful for our project. Therefore, we truncate the curves and make the
equivalence measurement within a specific range. The majority of meaningful information
for authentication is contained between the systolic peak and the dicrotic notch of the pulse
waves. Thus, we will make sure that we retain that part of the waveform for testing equiva-
lence.
Let yˆ(t), where t ∈ (0, 1), denote the estimated smoothing curve using nonparametric
regression for the reference data. We first determine the evaluation range [T1, Tr] where the
majority curves from the reference group have positive values. The values of T1 and Tr can
be determined from the functional boxplot of the reference data where the maximum non-
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Figure 4.4: Population Mean A and Mean C with the evaluation range of [0.06, 0.65].
outlying envelope is almost all positive. Let Dt be the time point where the first derivative
of the sample mean curve yˆ(t) gets the maximum, and Mt be the point where the mean
curve yˆ(t) reaches the first peak (maximum). We define the largest value among T1, Dt,
and 1
2
Mt as the left truncation point Tl, namely, Tl = max{T1, Dt, 12Mt}. We then apply
NBFET on the evaluation range [Tl, Tr]. For example, we generate a group of 50 curves from
Brownian motion with Mean C and variance of 40 as the reference data and the functional
boxplot is shown in Figure 4.3. We will select [T1, Tr] = [0, 0.65] as the initial range since
its non-outlying envelope is almost all positive. By take the first derivative of the sample
mean curve yˆ(t), we get Dt = 0.05 and Mt = 0.12. Therefore, the left truncation point
Tl = max{0, 0.05, 12 ∗ 0.12} = 0.06, and the evaluation range [Tl, Tr] = [0.06, 0.65]. Figure
4.4 shows the population mean curves from Mean A and Mean C, with the evaluation range
[0.06, 0.65]. Table 4.1 shows an example of the evaluation ranges for each of the reference
mean with a specific value of average of CV. For example, if we generate a group of curves
from a Brownian motion with Mean A and variance of 40 as the reference data, we will apply
the equivalence tests on the evaluation range of [0.06, 0.6].
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Reference Mean Variance of Brownian motion Average of CV Evaluation range
Mean A 40 0.146 [0.06, 0.6]
Mean B 40 0.125 [0.075, 0.6]
Mean C 40 0.172 [0.07, 0.65]
Mean D 25 0.162 [0.095, 0.65]
Mean E 25 0.136 [0.095, 0.65]
Mean F 40 0.141 [0.06, 0.6]
Table 4.1: The evaluation range for each of the reference mean with a specific value of
average of CV.
Ref Data Test Data average of CV EBs # rejecting Clopper-Pearson CI
Ha True Mean A Mean A 0.146 (0.8, 1.25) 999/1000 (0.994, 0.999)
Var=40 Var=40 (0.75, 1.33) 1000/1000 (0.996, 1.000)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean A Mean A 0.244 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=80 Var=80 (0.75, 1.33) 965/1000 (0.952, 0.976)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean A Mean A 0.314 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=100 Var=100 (0.75, 1.33) 660/1000 (0.629, 0.689)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean A Mean A 0.486 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=120 Var=120 (0.75, 1.33) 26/1000 (0.0171, 0.0379)
(0.7, 1.43) 992/1000 (0.984, 0.997)
Table 4.2: The null hypothesis of difference is false since the reference and the test data are
generated from the same mean. We compute the powers of the tests for different average of
CV and EBs. EB represents equivalence band and CI represents confidence interval.
4.3.3 Simulation Results for Various Equivalence Bands
Let µR(t) denote the population mean curve for the reference group and µT (t) represent the
population mean for the test group. We consider the ratio of two mean curves as a metric
for equivalence and conduct the following hypotheses:
H0 :
µT (t)
µR(t)
> U(t) or
µT (t)
µR(t)
< L(t)
Ha : L(t) ≤ µT (t)
µR(t)
≤ U(t)
where (L(t), U(t)) is the predefined equivalence band (EB).
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We first consider the case where the reference and the test data are from the same known
population mean. In this case, the null hypothesis of difference is false since the reference,
and the rest data are actually from the identical mean. For example, we generate groups of
fifty curves from a Brownian motion with Mean A as both the reference and the test data.
We then apply NBFET to the curves within the evaluation range discussed in Section 4.3.2,
and the results are shown in Table 4.2. From the first part of Table 4.2, we can see that
when we use a variance of 40 in the Brownian motion, namely, the average of point-wise CVs
for the reference data is 0.146, we successfully reject H0 of difference 999 out of 1000 times
when the equivalence band is (0.8, 1.25), and Clopper-Pearson confidence interval for power
is (0.994, 0.999). With wider equivalence margins of (0.75, 1.33) or (0.7, 1.43), we reject all
1000 times and get observed power of 100%. We also consider other options of variances,
denoted by σ2, to cover a wide range of CVs for real-life situations. We can see that when
the variance of Brownian motion increases from 40 to 80, the average of point-wise CVs
goes up to 0.244, the power of the test decreases from 0.999 to 0 if the equivalence band is
(0.8, 1.25). With wider equivalence band of (0.75, 1.33), the power of the equivalence test
goes down from 100% to 96.5%. When the average of the point-wise CVs gets larger say,
0.486, the narrower equivalence bands of (0.8, 1.25) and (0.75, 1.33) do not provide good
power even though the reference and the test data are actually from the same population
mean. However, the power is still high (99.2%) when we use the widest bands of (0.7, 1.43).
Table 4.3 show the simulation results when the reference and the test data are generated
from Brownian motion with Mean B, Mean C, and Mean D. The complete simulation results
are shown in Appendix A. From the simulation, the equivalence bands of (0.8, 1.25) works
well when the average of CVs is smaller than 0.2, however, when the CVs increase to 0.2
but are lower than 0.3, we may enlarge the equivalence bands to (0.75, 1.33). It will be
appropriate to use the equivalence bands of (0.7, 1.43) when the average of CVs is beyond
0.3.
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Ref Data Test Data average of CV EBs # rejecting Clopper-Pearson CI
Ha True Mean B Mean B 0.125 (0.8, 1.25) 998/1000 (0.993, 0.999)
Var=40 Var=40 (0.75, 1.33) 1000/1000 (0.996, 1.000)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean B Mean B 0.218 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=60 Var=60 (0.75, 1.33) 935/1000 (0.918, 0.949)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean B Mean B 0.334 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=100 Var=100 (0.75, 1.33) 522/1000 (0.491, 0.553)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean B Mean B 0.467 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=120 Var=100 (0.75, 1.33) 2/1000 (0.006, 0.021)
(0.7, 1.43) 990/1000 (0.981, 0.995)
Ha True Mean C Mean C 0.172 (0.8, 1.25) 997/1000 (0.991, 0.999)
Var=40 Var=50 (0.75, 1.33) 1000/1000 (0.996, 1.000)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean C Mean C 0.225 (0.8, 1.25) 46/1000 (0.034, 0.061)
Var=80 Var=80 (0.75, 1.33) 972/1000 (0.960, 0.981)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean C Mean C 0.313 (0.8, 1.25) 4/1000 (0.00109, 0.0102)
Var=100 Var=100 (0.75, 1.33) 489/1000 (0.458, 0.520)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean C Mean C 0.429 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=120 Var=120 (0.75, 1.33) 147/1000 (0.126, 0.170)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean D Mean D 0.142 (0.8, 1.25) 999/1000 (0.994, 0.999)
Var=25 Var=25 (0.75, 1.33) 1000/1000 (0.996, 1.000)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean D Mean D 0.238 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=40 Var=40 (0.75, 1.33) 892/1000 (0.871, 0.910)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean D Mean D 0.349 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=50 Var=50 (0.75, 1.33) 420/1000 (0.389, 0.451)
(0.7, 1.43) 944/1000 (0.928, 0.957)
Ha True Mean D Mean D 0.430 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=60 Var=60 (0.75, 1.33) 34/1000 (0.0237, 0.0472)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Table 4.3: Continued: The null hypothesis of difference is false since the reference and the
test data are generated from the same mean. We compute the powers of the tests for different
EBs. EB represents equivalence band and CI represents confidence interval.
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4.4 Determination of the Equivalence Bands
Based on the simulation results we got from Section 4.3.3, we decide to use equivalence
bands of (0.8, 1.25) when the CV for the reference data at time t, denoted CV (t), is less
than 0.2, equivalence bands of (0.75, 1.33) when the CV at time t is between 0.2 and 0.3,
and equivalence bands of (0.7, 1.43) when the CV at time t is between 0.3 and 1. It does not
make sense to evaluate equivalence when the standard deviation is larger than the mean;
thus, we truncate the curves at t when CV (t) > 1 for reference data. If CV (t) > 1 occurs
before the dicrotic notch, we still truncate at t when CV (t) > 1 because we believe that
the equivalence can hardly be measured when the standard deviation is bigger than the mean.
We define the EB = (L(t), U(t)) which determines whether the null hypothesis of differ-
ence is true or false. If the ratio of two population means falls entirely within the EB, then
the null hypothesis of difference is false. The interval (L(t), U(t)) is determined by the CV
of the reference data. In other words, for the following hypotheses in an equivalence test,
H0 :
µT (t)
µR(t)
> U(t) or
µT (t)
µR(t)
< L(t)
Ha : L(t) ≤ µT (t)
µR(t)
≤ U(t)
where µR(t) and µT (t) represent the population mean for the reference and test, respec-
tively. The EB = (L(t), U(t)) = (0.8, 1.25) when CV (t) < 0.2, (L(t), U(t)) = (0.75, 1.33)
when 0.2 ≤ CV (t) < 0.3, and (L(t), U(t)) = (0.7, 1.4) when 0.3 ≤ CV (t) < 1, where CV (t)
is the CV for the reference data at time t. In another words, the equivalence bands are
(L(t), U(t)) =

(0.8, 1.25), if CV (t) < 0.2
(0.75, 1.33), if 0.2 ≤ CV (t) < 0.3
(0.7, 1.4), if 0.3 ≤ CV (t) < 1.
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The equivalence bands proposed above constitute one of the main contributions in this
work. Currently, FDA suggests (0.8, 1.25), which is symmetric in the ratio scale, as the
equivalence limits to assess the bioequivalence for a scalar measure of similarity, such as AUC
and the maximum concentration. For highly variable drugs, the limits could be widened to
(0.75, 1.33) or even to (0.7, 1.43), depending on the within-subject CV. However, these is no
literature or guidance in determining the equivalence limits for a functional measurement of
similarity.
4.5 Nonparametric Bootstrap with Corrected Equiva-
lence Bands
In this section, we will implement NBFET procedure using the EB determined from Sec-
tion 4.4. Table 4.4 shows examples where the null hypothesis of difference is false, i.e., the
reference and the test data are generated from the population means which are practically
equivalent. In the first case, we generate the data from Brownian motion with the same
Mean A, and variances of 40, 80, 100, and 120, respectively. The power of the test decreases
from 0.999 to 0.89 when the variation increases from 40 to 120 (the average of CV goes up
from 0.146 to 0.486). In the second case, the reference and the test data are generated from
two different population means Mean E and Mean D, but the null of difference is still false
since the ratio of the population means falls entirely within the EB (Figure 4.5). The power
of the test goes down from 0.999 to 0.932 when the average of CV increases from 0.162
to 0.416. In the third and fourth cases, the null hypothesis of difference is still false since
the ratio of population means is completely contained in the EB. The powers of the tests
decrease slightly when the mean values of CV increase. In these four cases, the corrected
EB performs well in the sense that the power is maintained at a relatively high level.
Next, consider the case when the null hypothesis of difference is true. Figure 4.6 (a) shows
the population Mean A and Mean B, and (b) shows the ratio of Mean A to Mean B within
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Ref Data Test Data average of CV # rejecting Clopper-Pearson CI
Ha True Mean A Mean A 0.146 999/1000 (0.9944, 0.9999)
Var=40 Var=40
Ha True Mean A Mean A 0.254 996/1000 (0.9898, 0.9989)
Var=80 Var=80
Ha True Mean A Mean A 0.314 966/1000 (0.9528, 0.9763)
Var=100 Var=100
Ha True Mean A Mean A 0.486 890/1000 (0.8689, 0.9087)
Var=120 Var=120
Ha True Mean E Mean D 0.162 999/1000 (0.9944, 0.9999)
Var=25 Var=25
Ha True Mean E Mean D 0.245 993/1000 (0.9856, 0.9972)
Var=40 Var=40
Ha True Mean E Mean D 0.328 980/1000 (0.9693, 0.9877)
Var=50 Var=50
Ha True Mean E Mean D 0.416 932/1000 (0.9146, 0.9468)
Var=60 Var=60
Ha True Mean A Mean C 0.146 982/1000 (0.972, 0.989)
Var=40 Var=40
Ha True Mean A Mean C 0.254 854/1000 (0.831, 0.875)
Var=80 Var=80
Ha True Mean A Mean C 0.314 945/1000 (0.929, 0.958)
Var=100 Var=100
Ha True Mean A Mean C 0.486 819/1000 (0.794, 0.842)
Var=120 Var=120
Ha True Mean B Mean C 0.125 964/1000 (0.951, 0.975)
Var=40 Var=40
Ha True Mean B Mean C 0.218 938/1000 (0.921, 0.952)
Var=80 Var=80
Ha True Mean B Mean C 0.334 887/1000 (0.866, 0.906)
Var=100 Var=100
Ha True Mean B Mean C 0.467 827/1000 (0.802, 0.850)
Var=120 Var=120
Table 4.4: The power of the equivalence test when the null hypothesis of difference is false,
i.e., the population means from the reference and the test group are considered equivalent.
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Figure 4.5: (a) Population Mean D and Mean E. (b) The ratio of Mean D to Mean E within
the evaluation range.
the evaluation range. From Figure 4.6 (b), we can tell that the null hypothesis of difference
is true since the ratio of two population means falls just above the upper initial equivalence
margin at the tail, and we expect the type I error rate around the significance level of 5%.
We compute the type I error rates for different averages of CV and summarize the results in
the first part of Table 4.5. When we generate the reference and the test data from Brown-
ian motion with the same variance of 40 (the average of CV is 0.132), we incorrectly reject
the null hypothesis of difference 60 out of 1000 times. The type I error rate is 0.06 with
the Clopper-Pearson confidence interval (0.0461, 0.0766). We then increase the variance of
Brownian motion to 80, 100, and 120, and get the corresponding type I error rates 0.025,
0.046, and 0.019. The type I error rates for all four cases with different averages of CV are
controlled around the significance level of 5%. In the second part of Table 4.5, we apply the
NBFET to curves generated from Brownian motion with the reference Mean A and the test
Mean F. From Figure 4.7, we can see that the null hypothesis of difference is true since the
ratio of two means does not fall entirely within the EB. The type I error rate of the test goes
down from 0.039 to 0.002 when the mean value of CV increases from 0.146 to 0.486. Figure
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Figure 4.6: (a) Population Mean A and Mean B. (b) The ratio of Mean A to Mean B
within the evaluation range.
4.8 (a) shows the population Mean B and Mean F, and (b) is the ratio of Mean F to Mean
B within the evaluation range. We expect the type I error rate much smaller than the level
of significance 5% since the ratio of two means shown in Figure 4.8 (b) is way more extensive
than the upper band at the tail. The last part of Table 4.5 confirms this low type I error rate.
The complete simulation results for all situations are shown in Appendix B. From the
simulation results based on the corrected EBs, we can see that when the null hypothesis of
difference is false, the powers of the test are all above 80%. When the null hypothesis of
difference is true, but the ratio of the population means just outside the equivalence bound-
aries, the type I error rates are controlled around the significance level of 5%. While the
type I errors are extremely small if the observed test statistic is way beyond the equivalence
boundaries. Therefore, the corrected EBs defined in Section 4.4 work well for the simulated
data, and they are likely to work for the real pulse waves as well.
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Ref Data Test Data average of CV # rejecting Clopper-Pearson CI
H0 True Mean B Mean A 0.132 60/1000 (0.0461, 0.0766)
Var=40 Var=40
H0 True Mean B Mean A 0.268 25/1000 (0.0162, 0.0367)
Var=80 Var=80
H0 True Mean B Mean A 0.308 46/1000 (0.0339, 0.0609)
Var=100 Var=100
H0 True Mean B Mean A 0.452 19/1000 (0.0115, 0.0295)
Var=120 Var=120
H0 True Mean A Mean F 0.146 39/1000 (0.0279, 0.0529)
Var=40 Var=40
H0 True Mean A Mean F 0.254 21/1000 (0.0130, 0.0319)
Var=80 Var=80
H0 True Mean A Mean F 0.314 8/1000 (0.00346, 0.0157)
Var=100 Var=100
H0 True Mean A Mean F 0.486 2/1000 (0.000242, 0.00721)
Var=120 Var=120
H0 True Mean B Mean F 0.132 3/1000 (0.000619, 0.00874)
Var=40 Var=40
H0 True Mean B Mean F 0.268 0/1000 (0.00000, 0.00368)
Var=80 Var=80
H0 True Mean B Mean F 0.308 1/1000 (0.0000253, 0.00556)
Var=100 Var=100
H0 True Mean B Mean F 0.452 0/1000 (0.00000, 0.00368)
Var=120 Var=120
Table 4.5: The type I error rate of the equivalence test when the null hypothesis is true.
The reference and the test data are generated from a Brownian motion with Mean B and
Mean A in the first case.
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Figure 4.7: (a) Population Mean A and Mean F. (b) The ratio of Mean F to Mean A within
the evaluation range.
Figure 4.8: (a) Population Mean B and Mean F. (b) The ratio of Mean F to Mean B within
the evaluation range.
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4.6 Simplification by Choosing Featured Points
In the previous sections, we considered the curves as functional data and evaluated the
equivalence on the entire time range. We now pick the feature points such as systolic peak,
the dicrotic notch, and diastolic peak, and perform the equivalence test on these individual
time points. If the equivalence can be concluded for each of the evaluation points, the overall
equivalence can then be reached for the whole curve. One of the primary purposes of this
section is to see if we can simplify the NBFET procedure we discussed in Section 3.3.2 but
also reach the same conclusion by considering only a group of featured evaluation points.
4.6.1 Determining the Featured Evaluation Points
In this section, we will discuss a strategy for selecting the evaluation points for simulated
data. Suppose we have a group of p curves as the reference data with known mean and
variance of Brownian motion. Let yˆ(t), t ∈ (0, 1) be the nonparametric regression estimate
for the reference data. We will perform the following steps to pick the feature points:
Step 1: We determine the evaluation range [Tl, Tr] as discussed in Section 4.3.2.
Step 2: Let Mt be the first peak of the mean curve yˆ(t) where its first derivative equals
zero. Pick Mt ±Km ∗∆t as the first set of evaluation points, where ∆t is a very short time
interval.
Step 3: Find the changing point (dicrotic notch) of the mean curve yˆ(t) where the first
derivative goes from increasing to decreasing, and denote it as Nt. Pick Nt±Kn ∗∆t as the
second set of evaluation points.
We would consider the following combinations of the evaluation points:
Case 1: Few evaluation points: Km = Kn = {0}. 2 evaluation points.
Case 2: Moderate evaluation points: Km = {0, 1, 2}, Kn = {0, 1, 2}. 10 evaluation points.
Case 3: Moderate evaluation points: Km = {0, 1, 2}, Kn = {0, 1, 2, 3, 4, 5}. 16 evaluation
66
points.
Case 4: More evaluation points: Km = {0, 1, 2, 3, 4, 5}, Kn = {0, 1, 2, · · · , 9, 10}. 32
evaluation points.
We consider only the first peak and dicrotic notch as the evaluation points in Case 1,
and extend to its neighborhood in Case 2, 3, and 4. For example, we select a distance of two
evaluation points as a neighborhood of both the first peak and the dicrotic notch in Case
2, which results in 10 total evaluation points. Case 1 has the fewest evaluation points and
Case 4 has the most. If the evaluation points are outside the range of [Tl, Tr], we use Tl as
the left ending point and Tr as the right ending point.
4.6.2 Simulation Results from Simplified Procedure
When the null hypothesis of difference is false and the reference data behaves equivalently
as the test data, the Nonparametric Bootstrap with corrected equivalence bands confirmed
the equivalence for all within-person and between-people comparisons in Section 4.5. If we
consider a smaller set of evaluation points, we will reach to the same conclusion but with a
slightly higher power. Therefore, we focus on the case when the null of difference is true and
see if evaluation based on a smaller set of measured points will lead us to an incorrect decision.
In the first case of Table 4.5, we considered the situation where the null of difference was
true and measured the equivalence between reference data from Mean A and test data from
Mean B. For example, if we generated the data from Brownian motion with a variance of
80 for both the reference and test data, the type I error of the equivalence test was 0.025.
The type I error increased to 0.046 when the variance of Brownian motion wnet up to 100.
Nonparametric Bootstrap with corrected equivalence bands worked well since we controlled
the type I error around the significance level of 5%.
Next, we want to see if the procedure could be simplified by measuring the equivalence
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Ref Data Test Data average of CV # rejecting Clopper-Pearson CI
H0 True Mean B Mean A 0.132 Case 1: 1000/1000 (0.996, 1.000)
Var=40 Var=40 Case 2: 1000/1000 (0.996, 1.000)
Case 3: 986/1000 (0.977, 0.992)
Case 4: 56/1000 (0.0426, 0.0721)
H0 True Mean B Mean A 0.268 Case 1: 998/1000 (0.993, 0.999)
Var=80 Var=80 Case 2: 998/1000 (0.993, 0.999)
Case 3: 966/1000 (0.953, 0.976)
Case 4: 33/1000 (0.0228, 0.0460)
H0 True Mean B Mean A 0.308 Case 1: 1000/1000 (0.996, 1.000)
Var=100 Var=100 Case 2: 1000/1000 (0.996, 1.000)
Case 3: 992/1000 (0.984, 0.997)
Case 4: 41/1000 (0.0296, 0.0552)
H0 True Mean B Mean A 0.452 Case 1: 999/1000 (0.994, 1.000)
Var=120 Var=120 Case 2: 999/1000 (0.994, 1.000)
Case 3: 989/1000 (0.980, 0.994)
Case 4: 17/1000 (0.00993, 0.0271)
Table 4.6: The null hypothesis of difference is true, but the simplified procedure concludes
the equivalence.
on a smaller set of evaluation points but still control the type I error. We considered the
same data as we used in the first case of Table 4.5 and computed the type I error rates for
each of the four cases mentioned in Section 4.6.1. We picked ∆t = 0.01, and the results were
shown in Table 4.6. The first part of Table 4.6 showed the situation where the reference
and the test data were generated from Brownian motion with Mean A and Mean B, and a
common variance of 40 for each of the four cases. Case 1 considered only two evaluation
points (the first peak and the dicrotic notch) and got a type I error rate of 1000/1000 = 1.
Case 4 measured equivalence on neighborhoods of the first peak and the dicrotic notch of
total 32 points, and controlled the type I error rate at 56/1000 = 0.056. When we increased
the variance of Brownian motion to 80, 100, and 120, only Case 4 maintained the type I
error at the desired level. In another word, the procedure failed to distinguish two sets of
curves which came from population means that behaved quite differently and incorrectly
identified them as equivalent when we reduced the number of evaluation points. We also
applied the similar procedure to comparing the curves generated from Brownian motion with
the reference Mean A and the test Mean F, and with the reference Mean B and the test
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Mean F. The simulation results are shown in Table 4.7. From Table 4.7, we can see that
when we increased the number of the featured points from Case 1 to Case 4, only Case 3
and Case 4 gave the type I error rates at the desired level. The procedure could not dif-
ferentiate two differently behaved means when we decreased the number of the feature points.
The false acceptance of equivalence is sometimes dangerous, for example, it will approve
unauthorized access to company’s critical business data, or allow an acquaintance to view
personal medical records or bank account details. Moreover, the cost of identifying two
different subjects as equivalent is much more than incorrectly concluding two similar persons
differ. Therefore, we prefer applying equivalent testing on the whole function instead of on
a small group of featured evaluation points. However, Case 4 with the most measurement
points could be a replacement when the procedure takes too long to execute.
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Ref Data Test Data average of CV # rejecting Clopper-Pearson CI
H0 True Mean A Mean F 0.146 Case 1: 999/1000 (0.994, 0.999)
Var=40 Var=40 Case 2: 785/1000 (0.758, 0.810)
Case 3: 47/1000 (0.0347, 0.0620)
Case 4: 17/1000 (0.00993, 0.0271)
H0 True Mean A Mean F 0.254 Case 1: 998/1000 (0.993, 0.999)
Var=80 Var=80 Case 2: 564/1000 (0.532, 0.595)
Case 3: 36/1000 (0.0253, 0.0495)
Case 4: 21/1000 (0.0130, 0.0319)
H0 True Mean A Mean F 0.314 Case 1: 982/1000 (0.972, 0.989)
Var=100 Var=100 Case 2: 611/1000 (0.580, 0.641)
Case 3: 28/1000 (0.0187, 0.0402)
Case 4: 2/1000 (0.0000242, 0.00721)
H0 True Mean A Mean F 0.486 Case 1: 967/1000 (0.954, 0.977)
Var=120 Var=120 Case 2: 145/1000 (0.124, 0.168)
Case 3: 4/1000 (0.00109, 0.0102)
Case 4: 0/1000 (0.00000, 0.00368)
H0 True Mean B Mean F 0.132 Case 1: 999/1000 (0.994, 0.999)
Var=40 Var=40 Case 2: 983/1000 (0.973, 0.990)
Case 3: 117/1000 (0.0977, 0.139)
Case 4: 3/1000 (0.000619, 0.00874)
H0 True Mean B Mean F 0.268 Case 1: 999/1000 (0.994, 0.999)
Var=80 Var=80 Case 2: 864/1000 (0.841, 0.885)
Case 3: 69/1000 (0.0541, 0.0865)
Case 4: 1/1000 (0.0000253, 0.00556)
H0 True Mean B Mean F 0.308 Case 1: 992/1000 (0.984, 0.997)
Var=100 Var=100 Case 2: 851/1000 (0.827, 0.873)
Case 3: 2/1000 (0.0000242, 0.00721)
Case 4: 0/1000 (0.00000, 0.00368)
H0 True Mean B Mean F 0.452 Case 1: 989/1000 (0.980, 0.994)
Var=120 Var=120 Case 2: 325/1000 (0.296, 0.355)
Case 3: 0/1000 (0.00000, 0.00368)
Case 4: 0/1000 (0.00000, 0.00368)
Table 4.7: Continued: The null hypothesis is true, but the simplified procedure concludes
the equivalence.
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Chapter 5
Conclusion
In the previous chapter, we introduced a procedure to determine the proper equivalence
bands from a simulation study and then applied the nonparametric bootstrap to curves
simulated from Brownian motion. The type I error rates of the test were controlled around
the nominal significance level of 5% and the powers were all above 80%. Here we apply
the nonparametric bootstrap procedure discussed in Section 3.3.2 to real pulse waves from
four of the persons to determine whether equivalence tests can actually perform identity
authentication. The real data applications and conclusions are summarized in Section 5.1.
We give a summary of contributions of this work in Section 5.2 and propose some future
work in Section 5.3.
5.1 Real Data Application
Recall the four representative persons we used in Chapter 2: Person 1, Person 2, Person
7, and Person 10. There are 57 pulse cycles from Person 1. Figure 5.1 shows the original
curves after truncating and shifting and the corresponding functional boxplot. We divide
the curves from Person 1 into two parts: the first 30 curves serve as the reference group
and the remaining 27 curves are taken to be the test group. From Table 2.2, we notice that
the p-value of the permutation test for comparing within Person 1 using the reference and
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Figure 5.1: The original curves and functional boxplot for Person 1.
the rest group is 0.53. Thus, we do not have enough evidence to conclude that these two
sets of curves come from two different people. To assure the identity, we further apply the
equivalence testing using the nonparametric bootstrap procedure discussed in Section 3.3.2
to see if we can confirm that these two sets of pulse waves generated from the same person.
According to the method for determining the evaluation range discussed in Section 4.3.2,
the range of equivalence evaluation for Person 1 is (0.06, 0.45). Therefore, we compare the
confidence interval computed from the nonparametric bootstrap procedure with the equiva-
lence bands in the range of (0.06, 0.45). If the 90% confidence interval falls entirely within
the equivalence bands between the time of 0.06 and 0.45, statistically significant equivalence
can be concluded for the two groups of curves from Person 1.
Figure 5.2 shows the 90% confidence interval for the ratio of the population mean curves
from the reference and the test group of Person 1. The equivalence bands are shown in red.
We see that the confidence interval falls completely with the equivalence bands between the
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Figure 5.2: 90% confidence interval for the ratio of population mean curves from Person
1, with the equivalence bands shown in red and the evaluation range in blue.
Figure 5.3: 90% confidence interval for the ratio of population mean curves from Person
10, with the equivalence bands shown in red and the evaluation range in blue.
equivalence range of (0.06, 0.45). Therefore, we conclude that the reference and the test sets
are generated from the same person. Namely, the identity is assured for Person 1. Similarly,
we can also authenticate the identity of Person 10 from Figure 5.3. Figure 5.3 indicates the
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90% confidence intervals for the ratio of the population mean curves from the reference and
the rest group of Person 10, with the equivalence bands shown in red. The evaluation range
computed according to Section 4.3.2 is (0.05, 0.46). Thus, we conclude that the reference and
the test groups are from the same person since the confidence interval falls entirely within
the equivalence limits in the evaluation range. However, from Figure 5.4, equivalence cannot
be concluded for Person 2 and Person 7. Table 2.2 shows that the permutation p-value for
comparing within Person 2 is 0.001. Therefore the first half and the second half curves are
generated from different population means. It is not surprising that the 90% confidence
interval falls outside the equivalence bands and we fail to confirm the identity of Person
10 from equivalence test. The permutation p-value for comparing within Person 7 is 0.32
as shown in Table 2.2. However, there is a lot of variability in curves from Person 7, and
some go below zero at around t = 0.4. Moreover, several pulse waves from Person 7 do not
seem to have the most appropriate starting points. Thus, the 90% confidence interval for
the ratio of the population means dramatically widens at the beginning and around time 0.4.
Figure 5.4: 90% confidence interval for the ratio of population mean curves from Person 2
and Person 7, with the equivalence bands shown in red.
In the present work, we explored the use of pulse waves collected using PPG for identity
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authentication. First, we visualized the pulse wave data using functional boxplots, which
gave an assessment of the shape of the data and identified unusual observations. Functional
boxplots also helped to adjust data by shifting pulse waves to a more appropriate starting
point. Functional ANOVA and permutation tests were then employed to demonstrate that
the identities in a small group of test subjects could be differentiated and compared by
their pulse waveforms. We successfully differentiated the four persons in the sample through
Functional ANOVA and permutation tests. The primary task of the project was to confirm
the identity of a person, i.e., decide whether a given person, the test subject, is whom they
claim to be, namely the reference subject. We developed a new equivalence testing procedure
using nonparametric bootstrap, including the process of building the equivalence hypothesis
and test statistics, determination of evaluation range and equivalence bands to determine
whether the pulse waves of the test subject and the pulse waves of the reference subject were
close enough to be considered equivalent. The identities of Person 1 and Person 10 were
successfully confirmed through the nonparametric bootstrap procedure. However, we could
not assure the identity of Person 2 and Person 7 due to issues such as large variabilities and
negative values at the tail of pulse waves, improper starting points, unstable environment
when the pulse waves were collected, poor settings of the pulse oximeters.
5.2 Summary of Contributions
The equivalence bands proposed in Section 4.4 are one of the main contributions in this work.
Currently, equivalence limits of (0.8, 1.25) are frequently used in the bioequivalence litera-
ture and also recommended by FDA. Instead of analyzing the individual profile as functional
data, the profile is usually reduced to some scalar values by computing the pharmacokinetic
characteristics, such as the area under the curve and the maximum concentration. For highly
variable drugs, the limits could be widened to (0.75, 1.33) or even to (0.7, 1.43), depending
on the within-subject CV. However, there is no literature or guidance in determining the
equivalence limits for a functional measurement of similarity. We employed a simulation
study to propose the proper EBs which are based on the point-wise coefficient of variances.
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Another contribution we made is to propose the NBFET procedure in Section 3.3.2. Fog-
arty and Small (2014) considered the difference in mean curves and the ratio of variances as
metrics for equivalence. They performed separate equivalence tests for these two measure-
ments of equivalence. In our work, we used the ratio of mean curves as the test statistic and
incorporate the variances into the determination of the equivalence bands. Therefore, both
the mean curve and the variance are included in the equivalence test, and we do not lose
information from either of them.
Moreover, we generated pulse wave-like curves from Brownian motion and demonstrated
that Brownian motion can be used to simulate other functional data with ———particular
patterns. To the best of our knowledge, there are no studies on the use of functional data
generated from Brownian motion to perform identity authentication using an equivalence test
or to determine the equivalence limits. The procedure to determine the evaluation range we
used in Section 4.3.2 may be only applicable to pulse waveforms. However, similar ideas or
steps could be employed to establish the range in an equivalence test for other examples of
functional data.
5.3 Future Work
In this paper, we first visualize the pulse waves by functional boxplots and get a sense of
behavioral patterns of the underlying mean curve. Then functional ANOVA was performed
via a permutation test to differentiate people as well as an equivalence test to confirm the
identity of persons. Functional ANOVA is described in Section 2.2 and permutation test in
Section 2.3. Section 3.3.2 introduced the nonparametric bootstrap procedure for assessing
equivalence, with the corresponding simulation results shown in Chapter 4. These are all
frequentist methodologies, and similar approaches also exist under the Bayesian framework.
For example, we could employ Bayesian functional ANOVA for differentiating the wave pat-
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terns of subjects. Markov chain Monte Carlo methods could be implemented, but there are
problems with both regarding convergence and computational time since the dataset in our
project is large. One possible solution is to use the integrated nested Laplace approximation
(INLA) so that very accurate approximations to the posterior marginals can be directly com-
puted. The main benefit of INLA is computational; where MCMC methods run for hours
and days, INLA provides precise estimates in seconds and minutes.
Fogarty and Small (2014) proposed to conduct the following three steps when using the
Bayesian framework for equivalence testing:
1. Define an equivalence region through expert consultation.
2. Define a probability value, called it γ, such that if P{Ha|Data} ≥ γ, equivalence may
be suggested. Using the suggestions of Jeffries (1961), a value of γ = 0.75 or γ = 0.95 may
be appropriate.
3. Specify prior distributions for the metrics of equivalence that are commensurate with
the researchers’ prior belief of the alternative being true relative to the null.
We suggested using functional measures of location to evaluate practical equivalence in
the frequentist case. However, it is not required to carry out a TOST in the Bayesian
paradigm. The Bayesian approach allows the computation of the posterior probabilities of
our functional metrics of equivalence which can then be compared to specified range directly.
In another word, we directly calculate P{Ha|Data} for each set of the equivalence hypothe-
ses. INLA could be used to get both the posterior and predictive distribution for the metrics
of equivalence.
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Appendix A
Additional Simulation Results for
Determining Equivalence Bands
This appendix shows the simulation results for determining the most appropriate EBs for
different options of average CV.
Ref Data Test Data mean of CV EBs # rejecting Clopper-Pearson CI
Ha True Mean E Mean E 0.136 (0.8, 1.25) 1000/1000 (0.996, 1.000)
Var=25 Var=25 (0.75, 1.33) 1000/1000 (0.996, 1.000)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean E Mean E 0.215 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=40 Var=40 (0.75, 1.33) 922/1000 (0.904, 0.938)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean E Mean E 0.337 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=50 Var=50 (0.75, 1.33) 636/1000 (0.605, 0.666)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean E Mean E 0.411 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=60 Var=60 (0.75, 1.33) 68/1000 (0.0532, 0.0854)
(0.7, 1.43) 984/1000 (0.974, 0.991)
Table A.1: The null hypothesis of difference is false. The power for different choices of
equivalence bands with different averages of CV.
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Ref Data Test Data mean of CV EBs # rejecting Clopper-Pearson CI
Ha True Mean F Mean F 0.141 (0.8, 1.25) 996/1000 (0.990, 0.999)
Var=40 Var=40 (0.75, 1.33) 1000/1000 (0.996, 1.000)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean F Mean F 0.239 (0.8, 1.25) 12/1000 (0.00621, 0.0209)
Var=80 Var=80 (0.75, 1.33) 979/1000 (0.968, 0.987)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean F Mean F 0.328 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=100 Var=100 (0.75, 1.33) 626/1000 (0.595, 0.656)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean F Mean F 0.408 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=120 Var=120 (0.75, 1.33) 147/1000 (0.126, 0.170)
(0.7, 1.43) 993/1000 (0.986, 0.997)
Ha True Mean B Mean C 0.125 (0.8, 1.25) 998/1000 (0.993, 0.999)
Var=40 Var=50 (0.75, 1.33) 1000/1000 (0.996, 1.000)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean B Mean C 0.218 (0.8, 1.25) 67/1000 (0.0523, 0.0843)
Var=80 Var=80 (0.75, 1.33) 988/1000 (0.979, 0.994)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean B Mean C 0.334 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=100 Var=100 (0.75, 1.33) 596/1000 (0.565, 0.627)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean B Mean C 0.467 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=120 Var=100 (0.75, 1.33) 244/1000 (0.218, 0.272)
(0.7, 1.43) 995/1000 (0.988, 0.998)
Ha True Mean D Mean E 0.162 (0.8, 1.25) 994/1000 (0.987, 0.999)
Var=25 Var=25 (0.75, 1.33) 1000/1000 (0.996, 1.000)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean D Mean E 0.264 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=40 Var=40 (0.75, 1.33) 826/1000 (0.801, 0.849)
(0.7, 1.43) 1000/1000 (0.996, 1.000)
Ha True Mean D Mean E 0.352 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=50 Var=50 (0.75, 1.33) 320/1000 (0.291, 0.349)
(0.7, 1.43) 925/1000 (0.906, 0.941)
Ha True Mean D Mean E 0.426 (0.8, 1.25) 0/1000 (0, 0.00368)
Var=60 Var=60 (0.75, 1.33) 10/1000 (0.00481, 0.0183)
(0.7, 1.43) 910/1000 (0.891, 0.927)
Table A.2: Continued: the null hypothesis of difference is false. The power for different
choices of equivalence bands with different averages of CV.
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Appendix B
Additional Simulation Results for
Validation
Ref Data Test Data average of CV # rejecting Clopper-Pearson CI
Ha True Mean B Mean B 0.125 889/1000 (0.868, 0.908)
Var=40 Var=40
Ha True Mean B Mean B 0.218 987/1000 (0.978, 0.993)
Var=80 Var=80
Ha True Mean B Mean B 0.334 989/1000 (0.980, 0.994)
Var=100 Var=100
Ha True Mean B Mean B 0.467 944/1000 (0.928, 0.957)
Var=120 Var=120
Ha True Mean C Mean C 0.172 937/1000 (0.920, 0.951)
Var=40 Var=40
Ha True Mean C Mean C 0.225 976/1000 (0.964, 0.985)
Var=80 Var=80
Ha True Mean C Mean C 0.313 986/1000 (0.977, 0.992)
Var=100 Var=100
Ha True Mean C Mean C 0.429 890/1000 (0.869, 0.909)
Var=120 Var=120
Table B.1: The null hypothesis of difference is false. The power of the test for difference
averages of CV based on the corrected equivalence bands.
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Ref Data Test Data average of CV # rejecting Clopper-Pearson CI
Ha True Mean D Mean D 0.162 958/1000 (0.944, 0.970)
Var=25 Var=25
Ha True Mean D Mean D 0.264 976/1000 (0.964, 0.985)
Var=40 Var=40
Ha True Mean D Mean D 0.352 984/1000 (0.974, 0.991)
Var=50 Var=50
Ha True Mean D Mean D 0.426 922/1000 (0.904, 0.938)
Var=60 Var=60
Ha True Mean E Mean E 0.136 865/1000 (0.842, 0.886)
Var=25 Var=25
Ha True Mean E Mean E 0.245 914/1000 (0.895, 0.931)
Var=40 Var=40
Ha True Mean E Mean E 0.328 955/1000 (0.940, 0.967)
Var=50 Var=50
Ha True Mean E Mean E 0.416 886/1000 (0.865, 0.905)
Var=60 Var=60
Ha True Mean F F 0.141 828/1000 (0.803, 0.851)
Var=40 Var=40
Ha True Mean F Mean F 0.239 927/1000 (0.909, 0.942)
Var=80 Var=80
Ha True Mean F Mean F 0.328 951/1000 (0.936, 0.964)
Var=100 Var=100
Ha True Mean F Mean F 0.408 865/1000 (0.842, 0.886)
Var=120 Var=120
Table B.2: Continued: the null hypothesis of difference is false. The power of the test for
difference averages of CV based on the corrected equivalence bands.
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Appendix C
R Programs
########################################
## R version 3.5.0 (2018 -04 -23)
## Packages used:
## fda Version 2.4.8
## fda.usc Version 1.4.0
## sm Version 2.2 -5.6
########################################
C.1 Functional Boxplots
## functional data analysis , such as functional boxplot
library(fda)
## Smoothing Methods for Nonparametric Regression and Density Estimation
library(sm)
## read the original curves for Person 1
person1 <-read.csv("/Users/mengjiaowu/Documents/Research/ModifiedData
/1-cycles2.csv",header=FALSE)
## the number of cycles
ncurves <-0.5*dim(person1 )[2] -1
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## the matrix for time and PPG values
T1<-matrix(0,nrow=dim(person1 )[1], ncurves)
W1<-matrix(0,nrow=dim(person1 )[1], ncurves)
## make the start time for each curve be zero
for (i in 1: ncurves ){
T1[,i]<-person1[,2*i+1]-min(person1[,2*i+1],na.rm=TRUE)
W1[,i]<-person1[,2*i+2]
}
## shift the curves so that they all start at zero
for (i in 1: ncurves ){
W1[,i]<-W1[,i]-W1[,i][1]
}
P1matrix <-matrix(0,nrow=ncurves ,ncol =71)
## smooth the original curves
for (i in 1: ncurves ){
P1matrix[i,]<-sm.regression(na.omit(T1[,i]),na.omit(W1[,i]),h=0.01 ,
eval.points=seq(0,0.84,by =0.012))$estimate
}
par(mfrow=c(1,2))
## make functional boxplots for Person 1
fbplot(t(P1matrix [,1:61]),x=seq(0,0.72,by=0.012) , method="MBD",
ylim=c(-500,3800), xlim=c(0,0.72),
fullout=TRUE ,xlab="Time",ylab="")
## add the title for the functional boxplot
title(main="Person 1")
## plot the original curves
plot(seq(0,0.72,by=0.012) , P1matrix [1 ,][1:61] , type="l",ylim=c(-500,3500),
xlab="Time",ylab="",main="Person 1")
for(i in 2: ncurves ){
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lines(seq(0,0.72,by=0.012) , P1matrix[i,][1:61] , col=i)
}
C.2 Functional ANOVA
## comparing four persons using ANOVA
library(fda.usc) ## functional ANOVA
## P1matrix is smoothing curves after truncation for person 1
## and each column represent a single pulse wave
mydata <-rbind(P1matrix ,P2matrix ,P7matrix ,P10matrix)
## compute the number of curves for each person
n1<-dim(P1matrix )[2]
n2<-dim(P2matrix )[2]
n7<-dim(P7matrix )[2]
n10 <-dim(P10matrix )[2]
## assign the lables for each person
group <-rep(c(1,2,7,10),c(n1,n2,n7,n10))
## one -way functional ANOVA based on 1000 bootstrap samples
res <-anova.onefactor(fdata(mdata),group ,nboot =1000 , plot=TRUE)
## save the graph
quartz.save("fanova6person.pdf","pdf",width =9)
C.3 Permutation Test
## permutation test using smoothed and shifted data to compare Person 1
##and Person 7
##the number of permutations
N<-1000
## P1matrix and P7matrix contain the smoothed and shift data
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## from Person 1 and Person 7
P1_7<-rbind(P1matrix [,1:61], P7matrix [ ,1:61])
## each permutation generated one value of difference in areas
Diff1_7<-rep(0,N)
## n1: the number of curves of Person 1
n1<-nrow(P1matrix)
for (s in 1:N){
time <-seq(0,0.72,by =0.012)
## randomly select n1 curves without replacement
sample <-sample (1: nrow(P1_7),n1)
traintime <-seq(0,0.72,by =0.012)
## create the training/reference data
traindata <-t(P1_7)[, sample]
num1 <-matrix(0,nrow=ncol(traindata),ncol=length(time))
dem1 <-matrix(0,nrow=ncol(traindata),ncol=length(time))
## compute the local linear regression estimate for the reference data
for (j in 1: length(time )){
for(i in 1:ncol(traindata )){
R<-var(na.omit(traindata[,i]))*diag(length(na.omit(traintime )))
weight <-chol2inv(chol(R))
num1[i,j]<-t(dnorm(na.omit(traintime)-time[j] ,0 ,0.01))%*%(diag(weight)
*na.omit(traindata[,i]))
dem1[i,j]<-t(dnorm(na.omit(traintime)-time[j] ,0 ,0.01))%*%diag(weight)
}
}
Numtrain <-apply(num1 ,2,sum)
Demtrain <-apply(dem1 ,2,sum)
## etatrain is the local linear regression estimate for the reference data
etatrain <-Numtrain/Demtrain
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#####################################################################
testtime <-seq(0,0.72,by =0.012)
testdata <-t(P1_7)[,-sample]
num1 <-matrix(0,nrow=ncol(testdata),ncol=length(time))
dem1 <-matrix(0,nrow=ncol(testdata),ncol=length(time))
## compute the local linear regression estimate for the test data
for (j in 1: length(time )){
for(i in 1:ncol(testdata )){
R<-var(na.omit(testdata[,i]))*diag(length(na.omit(testtime )))
weight <-chol2inv(chol(R))
num1[i,j]<-t(dnorm(na.omit(testtime)-time[j] ,0 ,0.01))%*%(diag(weight)
*na.omit(testdata[,i]))
dem1[i,j]<-t(dnorm(na.omit(testtime)-time[j] ,0 ,0.01))%*%diag(weight)
}
}
Numtest <-apply(num1 ,2,sum)
Demtest <-apply(dem1 ,2,sum)
## etatest is the local linear regression estimate for the test data
etatest <-Numtest/Demtest
## compute the difference between two estimated curves
h<-etatrain -etatest
tdiff <-0.012
## compute the area between two curves using trapzoid rule
Diff1_7[s]<-sum(abs(h[-1]+h[-length(h)])*tdiff/2)
}
## We computed the difference between the area under the estimated curve
## from Person 1 and from Person 7 is 121.595
p_value=mean(Diff1_7 >121.595)
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C.4 Brownian motion
## generate the curves from Brownian motion
xx<-seq(0,1,by =0.01)
## the mean is a mixture of Beta densities
mean.vector <-500*dbeta(xx ,2.1 ,12)+550*dbeta(xx ,4,5)
## the variance for the Brownian motion
vari <-40
## number of realizations
nreal <-50
## number of grid points
np<-100
## generate a group of 50 curves from Brownian motion
## with the given mean and varaince
mydata <-matrix(0,nrow=nreal ,ncol=length(mean.vector ))
fit <-matrix(0,nrow=nreal ,ncol=length(mean.vector )-1)
for (i in 1: nreal){
## generate values from normal distribution with mean 0 and variance=vari
dis <-rnorm(np ,0,vari)
dis <-c(0,dis)
## compute the cumulatice sum
dis <-cumsum(dis)
## curve generated from Brownian motion with a given mean and variance
mydata[i,]<-mean.vector+dis
## apply the nonparametric regression smoothing
fit[i,]<-sm.regression(xx ,curve1[i,],h=0.025 , ngrid=np)$estimate
}
par(mfrow=c(1,2))
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## plot the simualted data
time <-seq(0,1,length=np)
plot(time ,fit[1,],type="l",ylim=c(-800,2800), col=4,ylab="",
main="Simulated curves after smoothing")
for (i in 2: nreal){
lines(time ,fit[i,],col=4)
}
## make a functional boxplot for the simulated data
fbplot(t(fit),x=seq(0,1,length=np),method="MBD",xlim=c(0,1))
title("Functional boxplot of the simulated curves")
C.5 Nonparametric Bootstrap
## Nonparametric bootstap for the ratio of mean curves
## First , we generate curves from Brownian motion with two given
## population means: mean.vector1 and mean.vector2
nreal <-50 ## 50 realizations for each mean
np<-100 ## the number of evaluation/grid points
xx<-seq(0,1,by =0.01)
mean.vector1 <-500*dbeta(xx ,2.1 ,12)+550*dbeta(xx ,4,5)
mean.vector2 <-500*dbeta(xx ,2.6 ,12)+450*dbeta(xx ,4,5)
## genetate curves from Brownian motion and store them in curve1 and curve 2
curve1 <-matrix(0,nrow=nreal ,ncol=length(mean.vector1 ))
curve2 <-matrix(0,nrow=nread ,ncol=length(mean.vector1 ))
## apply nonparametric regression (smoothing) to curve1 and curve2 ,
## and store the results in fit1 and fit2
fit1 <-matrix(0,nrow=nreal ,ncol=np)
fit2 <-matrix(0,nrow=nreal ,ncol=np)
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for (i in 1: nreal){
dis <-rnorm(np ,0,vari1)
dis <-c(0,dis)
dis <-cumsum(dis)
curve1[i,]<-mean.vector1+dis
fit1[i,]<-sm.regression(xx ,curve1[i,],h=0.025 , ngrid=np)$estimate
}
for (i in 1: nreal){
dis <-rnorm(np ,0,vari2)
dis <-c(0,dis)
dis <-cumsum(dis)
curve2[i,]<-mean.vector2+dis
fit2[i,]<-sm.regression(xx ,curve2[i,],h=0.025 , ngrid=np)$estimate
}
## Then , we apply the nonparametric bootstrap to fit1 and fit2
## the number of bootstrap samples
bsample <-1000
## the number of iterations
niter <-500
## Ratio stores the ratios of the estimated curves of the
## reference and the test group from each iteration
Ratio <-matrix(0,nrow=bsample ,ncol=np)
## equivalence indicates if we reject the null of difference
## in each iteration
equivalence <-rep(-1,niter)
for (i in 1: niter){
smRef_1<-matrix(0,nrow=bsample ,ncol=np)
smTest_1<-matrix(0,nrow=bsample ,ncol=np)
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for (k in 1: bsample ){
Time <-seq(0,1,length=np)
## draw bootstrap samples for the reference group
Cref <-sample (1:nreal ,nreal ,replace=TRUE)
dataRef <-fit1[Cref ,]
## draw bootstrap samples for the test group
Ctest <-sample (1:nreal ,nreal ,replace=TRUE)
dataTest <-fit2[Ctest ,]
## compute the nonparametric regression estimate for repeated measurement
## curves for both the reference and the test group
smRef_1[k,]<-sm.rm(Time ,dataRef ,minh =0.01 , maxh =0.01 , display="none")
$aux$mean
smTest_1[k,]<-sm.rm(Time ,dataTest ,minh =0.01, maxh =0.01, display="none")
$aux$mean
}
## compute the ratio of the estimated curves
for (k in 1: bsample ){
Ratio[k,]<-smTest_1[k,]/smRef_1[k,]
}
## compute the 90% confidence interval from bootstrapping results
ratio_statqt <-apply(thetaRatio ,2,function(x)
{quantile(x,probs=c(0.05 ,0.95) , type =7)})
## if the confidence interval falls entirely within the equivalence limits ,
## we conclude the equivalence
equivalence[i]<-ifelse(min(ratio_statqt [1,])> 0.8
& max(ratio_statqt [2 ,]) <1.25,1,0)
}
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